23.12.2012 Views

India Inc Goes Abroad - MAPE Advisory Group

India Inc Goes Abroad - MAPE Advisory Group

India Inc Goes Abroad - MAPE Advisory Group

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>India</strong> <strong>Inc</strong> <strong>Goes</strong> <strong>Abroad</strong><br />

<strong>India</strong>n Companies' Foreign Acquisitions - Jan 2000 to Mar 2006<br />

This study was prepared as a background paper for the Seminar hosted by the IIM Calcutta Alumni<br />

Association on “<strong>India</strong> <strong>Inc</strong> Going <strong>Abroad</strong> – Investing and Managing Internationally’ at the Leela Palace,<br />

Bangalore on April 19, 2006.<br />

This research report was compiled by Jacob Mathew (jacob@mapegroup.com, +91-98450 63025)<br />

and Sunil Jain (sunil@mapegroup.com, +91-99801 89000) of <strong>MAPE</strong> <strong>Advisory</strong> <strong>Group</strong>


THE BIG PICTURE<br />

Overview<br />

A steel company in Thailand, a boutique hotel in Australia, a truck manufacturer in Russia, a generic drug company in Belgium, a<br />

telecom firm in Bermuda and a offshore oilfield in Australia; all of them have one thing in common - they are all flying the <strong>India</strong>n<br />

tricolor. Outcome of a new trend of <strong>India</strong>n companies going abroad and acquiring overseas assets. The "<strong>India</strong>n multinational" has<br />

finally come of age. Global Investment bankers are courting <strong>India</strong>n companies more as buyers than as sellers. Suddenly <strong>India</strong>n buyers<br />

have become a force to reckon with in many industries such as pharma, auto components and oil/gas.<br />

As per our research, <strong>India</strong>n companies acquired 244 foreign companies in the last six years (Jan 01, 2000 to March 31, 2006). The<br />

number of <strong>India</strong>n companies that are investing abroad has been steadily rising ever since the flagship deal of Tata <strong>Group</strong> acquiring<br />

UK's Tetley Tea for US$431.2mn five years ago. In the calendar year 2005, there were more outbound cross-border deals than in-bound<br />

deals; incidentally this was the first time that there were more <strong>India</strong>n companies buying foreign assets than foreign companies buying<br />

<strong>India</strong>n assets. The volume of outbound deals was more than twice the volume of in-bound deals in 2005.<br />

Overseas Acquisitions by <strong>India</strong>n Companies<br />

In 2005, <strong>India</strong> <strong>Inc</strong>. shelled out more than US$3.5 bn acquiring stakes in 104 overseas companies. In the first three months of 2006,<br />

<strong>India</strong> <strong>Inc</strong> has invested US$1.15 bn for buying 17 companies overseas.<br />

What does this signify? Are <strong>India</strong>n companies looking more outwards? What drives this new trend of increasing out-bound crossborder<br />

deals? This report looks to answer these questions by looking at the out-bound cross border deals done by <strong>India</strong>n companies.<br />

Before we look at the study results it would be useful to pause and take a good hard look at the raw data on out-bound cross border<br />

deals done by <strong>India</strong>n companies.<br />

Research Methology<br />

Value (US$mm)<br />

4000<br />

3500<br />

3000<br />

2500<br />

2000<br />

1500<br />

1000<br />

500<br />

0<br />

2000 2001 2002 2003 2004 2005 Q106<br />

Source: Bloomberg, Merger Markets, Mape<br />

Value No of Deals<br />

Data on cross-border capital flows have always been problematic. In fact, just the footnotes in the official capital flow statistics of IFC<br />

and UNCTAD will qualify as a stand-alone research thesis. Trade literature and specifically asset-trade literature have long debated on<br />

the usefulness and reliability of cross-border capital flow data. The usual problems associated with the data include the wrong reporting<br />

of the investor country, transfer between affiliate companies wrongly classified as investments and general opaqueness in capital flow<br />

data. For instance an US company investing in an <strong>India</strong>n business through a Mauritius holding company is officially tracked as capital<br />

flow from Mauritius into <strong>India</strong>. So much so that in the early years following liberalization the <strong>India</strong>n Government routinely published<br />

data showing Mauritius as the largest foreign investor in <strong>India</strong> forgetting the fact that most of these investors were "located" at Edith<br />

Cavell Street in Port Louis in Mauritius.<br />

For the purposes of this study, we looked at cross-border <strong>India</strong>n M&A data collated by various sources including Bloomberg, Merger<br />

Markets and Reserve Bank of <strong>India</strong>. We had a starting list of 300+ outbound deals done by <strong>India</strong>n companies in the period Jan 1, 2000<br />

to March 31, 2006.<br />

1<br />

120<br />

100<br />

80<br />

60<br />

40<br />

20<br />

0<br />

No. of Deals


The Big Picture<br />

This starting list of out-bound deals included a host of deals that would not normally qualify as an out-bound deal by an <strong>India</strong>n<br />

company. For identifying the deals we scanned the data sources and media reports for information on all "<strong>India</strong>n companies" buying<br />

"overseas companies/ assets" considering the highlighted terms as conventionally understood in general parlance.<br />

Problems with the data include the infirmities associated in certain deals as below:<br />

<strong>India</strong>n companies buying the <strong>India</strong>n operations of foreign corporations. E.g. Nicholas Piramal's buy-out of Rhone-Poulenc's <strong>India</strong>n<br />

subsidiary or AV Birla <strong>Group</strong>'s buy-out of PSI Data Systems from <strong>Group</strong> Bull. Both deals mentioned are technically as<br />

out-bound deals done by <strong>India</strong>n companies as actual deal consideration had passed on from an <strong>India</strong>n buyer to a foreign<br />

seller; in our opinion such deals are domestic deals as the asset/business being transacted is principally <strong>India</strong>n in nature<br />

and operations.<br />

<strong>India</strong>n companies buying foreign corporations whose principal activities are located in <strong>India</strong>. E.g. Crisil's buy-out of London based<br />

Irevna, an equity research BPO Company and many such similar deals in the software sector. Many small to medium<br />

<strong>India</strong>n software companies are structured as subsidiaries of overseas located holding companies, which also act as the<br />

front-end sales and marketing arm of the <strong>India</strong>n operations. Here again our view is that such deals are essentially <strong>India</strong>n in<br />

nature.<br />

<strong>India</strong>n companies buying foreign corporations through their foreign resident affiliates or holding companies. Such deals do not usually figure<br />

in the usual out-bound capital flows, as the buyer is a foreign resident entity. Case in point is Scandent Solutions'<br />

US$120mn buy-out of Cambridge mortgage BPO operations. In our view, this is essentially an out-bound deal involving<br />

an <strong>India</strong>n company.<br />

In the M&A world, many companies including publicly traded companies are often loath to disclose deal details. Confidentiality<br />

agreements with counterparties and problems associated with past deal metrics being used (or misused) in negotiations in future deals<br />

are often cited as reasons for this behavior. Consequently, most information on deal sizes available publicly tends to be off the mark.<br />

A third problem is the substantial difference in the data points provided/used by the different agencies. For instance, Grant Thornton<br />

estimates that <strong>India</strong>n companies did a total of 136 outbound deals with a total value of US$4.3 bn in 2005 while Asiamoney put the<br />

same count at 54 deals totaling US$4.75 bn. During the same period, Reserve Bank estimates that the total stock of "direct investments<br />

abroad" by <strong>India</strong>n companies rose from US$7.1 bn in 2004 to US$9.6 bn. An interesting aside is that as per RBI statistics, the total<br />

stock of direct investment into <strong>India</strong> in end 2005 was US$44.5 bn signifying that <strong>India</strong>n out-bound deals are 20% stake in value<br />

compared to <strong>India</strong> bound foreign investment.<br />

To mitigate the effect of these factors, we have attempted to have a<br />

bottoms-up approach for this study by looking separately at all the<br />

individual deals during the period. We have re-worked the raw data for<br />

these and other discrepancies and have instead focused on the substance<br />

rather than on the form of the deal. Thus our deal list includes the<br />

Scandent-Cambridge deal but not the Crisil-Irevna deal or the<br />

Piramal/Rhone Poulenc deal. We looked at multiple data sources,<br />

spoke at times to the company/investment banker involved in the deal,<br />

used our knowledge of the M&A environment to interpret conflicting<br />

data points - all in order to paint what we hope would be a<br />

comprehensive picture of <strong>India</strong>n companies buying overseas<br />

companies/assets.<br />

For this study, we analyzed 244 deals in the period January 2000 to<br />

March 2006. The ensuing pages of this report discusses the general<br />

trends across industries and then goes on to discuss the industry<br />

perspective for the main sectors which have witnessed significant cross<br />

border deals. We finally detail all the 244 deals that were done during<br />

the study period.<br />

2<br />

Sectorwise breakup by Volume of Deals<br />

Oil & Gas, 13<br />

Chemicals &<br />

Fertilizers, 17<br />

Automotives, 24<br />

Metals &<br />

Mining, 11<br />

Consumer, 10<br />

Software /<br />

BPO, 82<br />

Other, 37 Healthcare, 50


The Big Picture<br />

Deal Landscape<br />

Our analysis shows that<br />

Software/BPO (33.6%) and Pharma/healthcare (20.5%) sectors account for more than half of the overseas acquisitions<br />

in terms of number of deals.<br />

Oil & Gas sector accounts for 18.6% of the total value of overseas acquisitions, largely due to the key acquisitions by<br />

ONGC.<br />

The average deal size stands at about US$35.1mn, though the average figure could be a misleading figure because of the<br />

presence of a few large deals involving large investments.<br />

The largest proportion of <strong>India</strong>n acquisitions have been in Europe (~40%) and North America (~34%), showing that<br />

<strong>India</strong>n companies are acquiring / investing in more developed economies.<br />

Except for few large transactions in the oil/gas, pharma and some other sectors most of these deals have been of low<br />

value and bulk of the deals have been below US$10mn in terms of outward investment. It seems that <strong>India</strong>n companies<br />

are treading carefully and minimizing their risk through value buys.<br />

Sector Value<br />

(US$mm)<br />

Note: Data between Jan 2000 and Mar 2006<br />

Why are <strong>India</strong>n Companies going abroad?<br />

A key factor compelling <strong>India</strong>n companies to look overseas is that in many industries the main market for growth is the now the global<br />

rather than the domestic market. In pharma and auto component industries, it is not uncommon to find companies with export<br />

revenues higher than or at the same level as domestic revenues. Software/BPO businesses in <strong>India</strong> have always been configured to serve<br />

export markets. In many industries, lowering trade barriers and entry of multinationals into the <strong>India</strong>n market have meant global<br />

competition in local markets. In the new paradigm, going global is an imperative rather than "one of the many available growth<br />

options" for many <strong>India</strong>n companies.<br />

A fast growing economy, an optimistically buoyant capital market and significant global investor interest into <strong>India</strong> have meant easy<br />

availability of capital for <strong>India</strong>n companies. Also easing regulations have permitted increased access to cheaper global funds. All this has<br />

resulted in a host of <strong>India</strong>n companies sitting on significant cash.<br />

Clearly, buying foreign companies is often an easier and less risky way of going global than the long hard way of setting up greenfield<br />

operations. Greenfield risk is often more pronounced in newer geographies. The need to go global is in most for <strong>India</strong>n companies in<br />

acquiring client relationships and distribution channels and not for manufacturing capacities. And in many <strong>India</strong>n industries, it makes<br />

sense for the top players to acquire overseas assets rather than <strong>India</strong>n assets. Overseas assets bring in a new dimension for the<br />

businesses and are often cheaper to buy than <strong>India</strong>n assets. <strong>India</strong>n pharma industry which saw more outbound cross border deals than<br />

domestic deals in the last year is a good example. Dr Reddy's and Ranbaxy bought significant European assets in Q1 of 2006 and both<br />

deals were priced in the 10-12x EBITDA range. Thanks to the booming stock markets, even run-of -the-mill domestic <strong>India</strong>n pharma<br />

companies enjoy a 15-20x P/E valuation in the <strong>India</strong>n markets.<br />

3<br />

% of deal<br />

value<br />

Deal<br />

Volume<br />

% of deal<br />

volume<br />

Automotives 427.3 5.0% 24 9.8%<br />

Chemicals & Fertilizers 655.2 7.7% 17 7.0%<br />

Consumer 668.5 7.8% 10 4.1%<br />

Healthcare 1,604.2 18.8% 50 20.5%<br />

Software / BPO 1,115.4 13.0% 82 33.6%<br />

Metals & Mining 970.5 11.3% 11 4.5%<br />

Oil & Gas 1,587.0 18.6% 13 5.3%<br />

Other 1,525.8 17.8% 37 15.2%<br />

Total 8,553.8 100% 244 100%


The Big Picture<br />

From the supply side perspective, availability of many companies for sale in Europe and USA and liquidation of private equity<br />

investments in these regions are often cited as primary triggers for overseas acquisition. Also, for many small to medium sized<br />

manufacturing companies in the developed economies, the changed economic environment has resulted in their existing business<br />

model no longer being tenable from a cost competitive angle. The writing is on the wall and it becomes imperative to restructure their<br />

businesses and re-work their cost structures. A Chinese or <strong>India</strong>n buyer is often the only savior in such cases as the ability to plug-in to<br />

a low cost country advantage is many a times the only panacea. Examples are legion. Grant Thornton estimated a "five fold increase" in<br />

the amounts invested by foreign buyers from developing countries such as China and <strong>India</strong> in the UK market (EUR 5.5bn in 2005 up<br />

from EUR 981mn in 2004). Examples cited included Tata Chemicals acquisition of Brunner Mond Holdings in November 2005 for<br />

US$ 111.2mn.<br />

Probably this twin edged demand and supply side drivers resulted in this splurge of cross-border deals that we witnessed from start of<br />

2005. Deal volumes in 2005 were up 110% by volume and 390% by value relative to 2004. Going by the deal count for the first quarter<br />

of 2006 which saw 17 deals totaling US$ 1.15bn, the current year will probably have significantly more international deals than 2005.<br />

The <strong>India</strong>n regulatory environment has also kept pace with the strides of the <strong>India</strong>n multinational. In January 2005 the <strong>India</strong>n<br />

government removed the US$100 mn cap on foreign investment by <strong>India</strong>n companies and raised it to the level of net worth of the<br />

acquiring <strong>India</strong>n companies. This move acted as a catalyst for foreign investments abroad. In March 2006, the Reserve bank of <strong>India</strong><br />

(RBI) liberalized several rules relating to overseas investment by <strong>India</strong>n companies. It cleared the road for proprietary/ unregistered<br />

partnership firms to set up JV or a wholly owned subsidiary abroad. The move will potentially enable diamond and commodity<br />

exporters - which are mostly family run concerns - to reap the benefit of globalization.<br />

What are <strong>India</strong>n Companies buying?<br />

The deal rationale is obviously different for the different deals. Is there an underlying theme for each industry or is that this big outward<br />

push is the sum total of the different growth strategies of the individual companies in a particular industry? It is difficult to draw<br />

necessary conclusions form such a large deal sample as ours that is spread across different geographies and over a long six year time<br />

period. However, we attempt to draw some inferences from industry specific deals.<br />

Software and BPO industry saw the largest deal count at 82 deals and is usually on the top for annual deal counts across the time<br />

period. However the deal sizes are invariably small in size and the sector has witnessed only four significant US$ 50mn+ deals in the<br />

study period- Scandent's Cambridge buy in Sep-05 for US$120mn, Patni's buy-out of Cymbal for US$67mn in Oct-04, Wipro's<br />

Newlogic deal in Dec-05 for US$56.4mn and WNS' buy out of Trinity's mortgage claims processing business for over US$60mn. Most<br />

acquisitions in this sector continue to be propelled by two main drivers - customer acquisitions and entry into new/niche domains. The<br />

sector has also seen a fair number of small sized deals involving small to medium sized <strong>India</strong>n companies buying overseas companies in<br />

smaller deals often in the US$1-5mn range.<br />

The size and nature of <strong>India</strong>n cross border deals by <strong>India</strong>n companies is insignificant given that export revenues are 90%+ for most<br />

<strong>India</strong>n companies and <strong>India</strong>n companies are a force to reckon with in the global market place both in size and stature. Scandent's<br />

Cambridge deal involving an <strong>India</strong>n company buying an overseas asset worth twice its own revenues is more an exception than the rule.<br />

<strong>India</strong>n companies continue to prefer to sit on their cash pile (the four large companies in the sector had total cash assets of more than<br />

US$1bn) and look for small value buys rather go after any transformational deals. An oft propounded theme in this sector is the buy<br />

out of a US or European business with a local delivery capability and then off shoring the foreign operations while keeping the front<br />

end intact. While this in theory is an excellent value preposition, successful examples of such deals are limited. Some of the small<br />

<strong>India</strong>n companies have burnt their hands badly in such maneuvers and the recent buy-out of some struggling US based BPO<br />

businesses by <strong>India</strong>n companies are still in the restructuring stages.<br />

An interesting point to note that the in-bound cross border deals in this sector have been significant in scope and size with global<br />

majors like IBM, Oracle, Flextronics and EDS investing significantly to buy <strong>India</strong>n software/BPO companies. <strong>India</strong>n companies who<br />

are already global or have global ambitions are still to invest abroad in a significant manner. Are <strong>India</strong>n companies reluctant to be<br />

aggressive or is that in the evolving structure of the industry <strong>India</strong> is the best or the only place to be in? Jury is still out.<br />

The <strong>India</strong>n pharma industry has been the poster boy for out bound cross-border deals from <strong>India</strong>. And unlike in the Software/BPO<br />

sector, pharma has witnessed more outbound activity than inbound deals in the cross border arena. First quarter of 2006 saw <strong>India</strong>n<br />

companies spending close to US$1 bn in buying up European assets. The increasing globalization of the <strong>India</strong>n pharma sector and the<br />

market access needs of the <strong>India</strong>n companies to successfully leverage their technical capabilities and low cost advantages in foreign<br />

markets are the main drivers for the heightened M&A activity.<br />

4


The Big Picture<br />

Again unlike the software sector, the big players like Dr Reddy's,<br />

Ranbaxy and Sun Pharma has been in the forefront of this cross<br />

border activity. Dr Reddy's acquisition of Betapharm in Feb 2006<br />

for US$ 570.3mn is the largest cross border acquisition by a<br />

private <strong>India</strong>n company. The expanding generic market in the<br />

developed nations, sustainable cost competitiveness enjoyed by<br />

<strong>India</strong>n companies, need for local operations to satisfy regulatory<br />

and market requirements and limited growth opportunities in the<br />

domestic market are all expected to continue to drive crossborder<br />

M&A activity in this sector.<br />

In the current environment, most <strong>India</strong>n pharma companies have<br />

more appetite for cross border than domestic deals. The stark<br />

difference in deal valuations in <strong>India</strong> and other markets as<br />

discussed earlier is one of the reasons for this. A more important<br />

factor is the possibilities associated with a foreign buy including<br />

expanding the product range of the acquired company, leveraging<br />

the acquired infrastructure to enter newer markets and value<br />

creation by plugging into <strong>India</strong> costs.<br />

An interesting point to note is that of late, <strong>India</strong>n companies have<br />

become the buyer of choice for most international auctions of<br />

pharma assets and investment bankers frequently talk about the<br />

newfound enthusiasm amongst European and American sellers to<br />

woo <strong>India</strong>n buyers. <strong>India</strong>n companies were recently reported to<br />

be seriously in the race for two separate billion-dollar transactions<br />

in the US though in the particular cases they were edged out in<br />

the last minute by the global generic majors. We expect significant<br />

more action on this industry and believe that we are close to<br />

seeing large transformational acquisitions by <strong>India</strong>n pharma<br />

companies.<br />

Oil & Gas sector has seen significant cross border activity led by<br />

the two public sector companies - ONGC and GAIL. In<br />

December 2005, ONGC bid and won a 45% stake in the Akpo<br />

deepwater oil and gas field in Nigeria from South Atlantic<br />

Petroleum for US$2bn, only to have the deal vetoed by the <strong>India</strong>n<br />

Government. ONGC had earlier invested US$136.5mn in 2003<br />

and US$766.1mn in 2002 to buy ownership interests in different<br />

Sudanese oil fields. ONGC's first significant foreign foray was for<br />

the Sakahalin project in Russia with an investment of US$323mn.<br />

ONGC's drive to acquire foreign assets has a geo political impact<br />

and <strong>India</strong>n/Chinese buyers are increasingly seen as serious<br />

contenders for overseas oil reserves to cater to their expanding<br />

energy needs. In this sector, GAIL has also acquired minority<br />

interests in gas distribution companies in Egypt and China. We<br />

foresee more cross-border deals in the refining and downstream<br />

sectors by players such as <strong>India</strong>n Oil.<br />

The <strong>India</strong>n automotive/ auto component sectors have also seen<br />

significant out-bound cross-border M&A activity. Tata Motors<br />

buy-out of Daewoo's commercial vehicle business in South<br />

Korea for US$118.2mn in November 2003 is the largest deal in<br />

this sector. Most of the deals in this sector have been done by a<br />

few companies/groups, which have been in the forefront of<br />

global acquisitions.<br />

5<br />

The Tata <strong>Group</strong> did five out bound deals totaling US$250mn in<br />

Korea, UK, Spain and Germany. Amtek Auto bought four<br />

companies across the US, UK, Germany and Bermuda markets.<br />

Bharat Forge did deals in US, Sweden, China and Germany.<br />

Mahindras were involved in acquisitions in China, Romania and<br />

UK. The TVS <strong>Group</strong> bought auto component assets in UK,<br />

Germany and Malaysia. Most of the other companies in this<br />

sector have shied away so far from foreign acquisitions. However,<br />

recent reports suggested that mid-sized <strong>India</strong>n auto component<br />

manufacturers were in the forefront for bidding for parts of a<br />

large troubled component business in the US. Media reports<br />

suggest that <strong>India</strong>n companies are seriously eyeing more foreign<br />

assets in the sector and this activity is bound to pick up with the<br />

increased globalization of the <strong>India</strong>n auto sector. Ability to plug<br />

into low cost <strong>India</strong>n manufacturing capabilities is often a<br />

significant value creator for cross border deals. Bharat Forge<br />

recently bought the forgings business of Tyco International with<br />

a view to relocate the business to its home locale at Pune,<br />

Maharashtra.<br />

Metals & Mining is another sector, which saw significant out<br />

bound deals. <strong>India</strong>n companies have gone abroad in search of<br />

captive access to natural resources for their own manufacturing<br />

facilities in <strong>India</strong>. Birla <strong>Group</strong> bought two copper mines in<br />

Australia spending US$100mn+ and Gujarat NRE Coke did three<br />

separate colliery deals in Australia. In metals, the push is to have a<br />

wider global manufacturing spread to cater to new markets and<br />

become a significant global player. Tata Steel acquired NatSteel<br />

Asia for US$283.7mn in 2003 and followed it up by buying the<br />

Thai company - Millennium Steel - for US$398.5mn 2005. Essar<br />

group acquired two steel mills in UK from Stemcor for about<br />

US$100mn. Jindals also have been active and bought assets in<br />

France and Indonesia.<br />

In other sectors, outbound deals have been driven by the desire to<br />

acquire international assets or capacity - either to support the<br />

acquirer's domestic operations as in the case of VSNL's purchase<br />

of Tyco Global Network in Nov 2004 for US$130mn and<br />

Teleglobe International Holdings in Jul 2005 for US$254.3m or<br />

Reliance's purchase of Flag Telecom in 2003 for US$191.2mn.<br />

Videocon's purchase of Thomson's picture tube businesses in<br />

Italy and China for a reported value of US$450mn in a structured<br />

transaction is instances of <strong>India</strong>n companies globalizing their<br />

production capacities. Similarly Apollo Tyres bought the South<br />

African based Dunlop Tyres in Jan 2006 for US$62mn.


The Big Picture<br />

How are <strong>India</strong>n companies paying for their deals?<br />

Most, if not all, of the significant overseas transactions done by<br />

<strong>India</strong>n companies have been paid for in cash. Stock transactions,<br />

the major form of M&A deals globally, have been noticeably<br />

absent in the <strong>India</strong>n transactions other than in a few reportedly<br />

large transactions in the software sector where the sellers (often<br />

of <strong>India</strong>n origin) have been comfortable with taking the stock of<br />

<strong>India</strong>n companies as the deal consideration.<br />

Why cash deals? Internationally more than 50% of the M&A<br />

deals are stock deals. However, historically <strong>India</strong> <strong>Inc</strong> has done<br />

cash deals for their domestic transactions; only a few of the<br />

domestic transactions have been stock deals. Almost <strong>India</strong>n<br />

companies are still owned directly by their promoter shareholders<br />

who are often directly in management. L&T and ICICI Bank are<br />

probably the only exceptions on this count. This contrast with the<br />

large publicly held corporations in the developed markets where<br />

there are no identified promoter groups and most public<br />

companies are "public" in the true sense of the word. Founder<br />

families, even when there, have little control over the companies<br />

they founded as in the case of Hewlett Packard which went ahead<br />

and consummated the large merger deal with Digital despite stiff<br />

opposition from its founders. Given the preponderance of<br />

family shareholding in the <strong>India</strong>n context, there is often<br />

reluctance from the buyer's part to bring in another family into<br />

the shareholding structure. This reluctance also extends to the<br />

Seller who is often more happy to have cash rather stock in a<br />

company run by another family. This peculiar <strong>India</strong>n reluctance to<br />

"share the table" is the main driver for cash transactions in the<br />

<strong>India</strong>n deal scope. Clearly, this preference of <strong>India</strong> <strong>Inc</strong> for cash<br />

transactions has extended to their international deals.<br />

Also, given the vagaries of the <strong>India</strong>n stock market it would be<br />

difficult to find a foreign Seller willing to accept buyer stock as<br />

consideration. Regulatory hassles associated with approval for<br />

stock issuance to foreigners for other than cash and capital<br />

market requirements on lock-in period for new stock issuance<br />

only further complicate this issue. While this aspect is mitigated<br />

for <strong>India</strong>n companies who are also listed in the foreign stock<br />

markets (through ADRs/GDRs), we are yet to see stock as a<br />

major currency for international deals originating from <strong>India</strong>.<br />

But does this constrain the <strong>India</strong>n buyer? Would <strong>India</strong>n<br />

companies have gone ahead and bought more companies<br />

internationally if they could do stock transactions? Probably not.<br />

<strong>India</strong>n companies seem happy doing large cash transactions.<br />

Funding sources are manifold. Easy liquidity in the <strong>India</strong>n debt<br />

markets and a booming capital market has meant easy availability<br />

of cash for <strong>India</strong>n buyers. A new trend that seems to be on is that<br />

of leveraged buy-outs for international transactions. This involves<br />

an <strong>India</strong>n buyer leveraging the acquired company's assets to debt<br />

finance the acquisition transaction - with such debt invariably<br />

being non-recourse in nature especially when the amounts<br />

involved are large. Dr Reddys' buy-out of Betapharm, Germany<br />

in 2006 for US$570mn was reportedly financed to the extent of<br />

50% of deal value by such non-recourse debt with the balance<br />

amount being financed through a planned FCCB (foreign<br />

6<br />

Different Environments, Different Strokes<br />

M&A behaviour of <strong>India</strong>n companies who have done<br />

multiple deals in foreign countries is remarkable for its<br />

range and uniqueness. Typically in the domestic<br />

environment, M&A behaviour of most <strong>India</strong>n<br />

companies are predictable. Most investment bankers who<br />

work closely with <strong>India</strong>n companies have a fair idea of<br />

what they want to buy and how much they will normally<br />

pay. The context however is quite different in the<br />

international deals done by many <strong>India</strong>n companies. Dr.<br />

Reddy's and Ranbaxy M&A buys in the last few months<br />

are example of the same buyer having different intents -<br />

strategic and opportunistic - depending on the<br />

environment.<br />

In February 2006, Dr. Reddy's bought Betapharm<br />

Arzneimittel GmbH from the European private equity<br />

house 3i for Euro 480mn. 3i had bought this company<br />

from Hexal in March 2004 for Euro 300mn. Betapharm<br />

is the fourth largest German generic company and had<br />

estimated sales of Euro 140 mn and operating profit<br />

(EBITDA) of Euro 40 mn. Dr. Reddy's purchase price<br />

was 3.4x sales and 12.5x EBITDA - a rich valuation for a<br />

rich market. Contrast this with Dr. Reddy's acquisition of<br />

Roche's custom synthesis business in Mexico for US$<br />

59mn in Nov 2005. Adjusted for working capital assets,<br />

the purchase price was less than 1 time revenues.<br />

Ranbaxy bought 96.7% stake in the Romanian generic<br />

player Terapia SA for US$324 mn in March 2006. Terapia<br />

had sales of US$ 80mn and Ranbaxy's purchase price was<br />

4.1x sales and 11.6x EBITDA. In the same week,<br />

Ranbaxy announced two more acquisitions - purchase of<br />

Ethimed in Belgium and Allen SpA, Glaxo's unbranded<br />

generic business in Italy. Company did not disclose details<br />

of both these deals; but analysts estimate both these deals<br />

to be priced at < $10mn and valued at about 1x time<br />

sales.<br />

currency convertible bond) issue at the <strong>India</strong>n parent level.<br />

Similarly Tata Tea's buy-out of Tetley, UK in 2000 for<br />

US$431.2mn was largely financed through leveraged debt<br />

without exposing the parent company's balance sheet to the<br />

success or otherwise of the acquired business.<br />

FCCB issues are increasingly the most popular route for raising<br />

large moneys for <strong>India</strong>n corporates esp. for acquisitions. Sun<br />

Pharma and Wockhardt raised US$350mn and US$100mn<br />

respectively in 2004-05 through FCCBs for funding planned<br />

foreign acquisitions. Wockhardt is reportedly raising another<br />

US$300mn through the FCCB route to fund its international<br />

M&A initiatives. Others who have raised such convertible<br />

include Glenmark Pharma, Tata Chemicals, Bharat Forge and<br />

Amtek Auto. The popularity of FCCB as an instrument is<br />

driven in main by the fact that most of these instruments are<br />

structured as 5-year paper with a low coupon rate.


The Big Picture<br />

The bondholder has the option to convert the bonds into equity shares at a pre-agreed valuation, which is usually at a 25-75% premium<br />

to the issuer's stock price at the time of issue. Thus the bond investor gets an option to participate in the possible upside in the stock<br />

price and capital preservation is guaranteed, as the conversion is optional. For the issuer, this works out as a low cost means of<br />

financing, as the FCCB coupon rates are usually 2-300points below the general debt coupon rates.<br />

How successful are <strong>India</strong>n companies in their international deals?<br />

The conventional wisdom in the international M&A literature is that only less than half of the M&A deals are a "success".<br />

Literature is replete with empirical studies to buttress this low success<br />

rate argument. Does <strong>India</strong> follow the international trends in this regard The Chinese Context<br />

or<br />

do we stand out? There are no significant studies' examining the success<br />

<strong>India</strong>n companies in their M&A deals. However, an informal <strong>India</strong>n<br />

dipstick study conducted by some investment bankers who together<br />

were involved in close to 100+ significant M&A deals in <strong>India</strong> seem to<br />

suggest that <strong>India</strong>n experience in this regard have been good. The study<br />

concluded that most of the <strong>India</strong>n companies were successful in their<br />

M&A endeavors with "success" being conventional defined as whether<br />

"are you better off in having the done the deal or not?"<br />

The peculiar <strong>India</strong>n question. How do we compare<br />

of<br />

with China? China's Ministry of Commerce states<br />

Chinese outbound foreign investment totaled $8.84<br />

billion in 2005, more than double the $3.78 billion in<br />

2004, which itself was more than double the $1.5<br />

billion in 2003. Large deals included CNOOC's<br />

purchase of Nigerian Akpo oil & gas fields (for which<br />

the <strong>India</strong>n Government refused permission for<br />

ONGC to buy after it had won the bid saying "cabinet<br />

took all factors into consideration and felt that this<br />

wasn't a commercial opportunity worth pursuing"),<br />

CNPC's buy of Canadian PetroKazhakstan for US$<br />

4.2bn, Lenovo's $1.25 billion acquisition of IBM's<br />

PC division and TCL International's majority-owned<br />

joint venture with French company Thomson, which<br />

got it the RCA brand and made TCL the world's<br />

largest TV manufacturer. State owned Nainjing<br />

Motors bought the troubled UK car maker MG Rover<br />

for US$87mn.<br />

Coming to international transactions of <strong>India</strong>n companies, it is a bit<br />

early to take the call as most of the large and significant transactions<br />

have happened only in 2005. However, early indications are that the<br />

international experience of <strong>India</strong>n companies in doing deals is a happy<br />

one. Tata Tea has successfully managed to integrate Tetley's operations<br />

with themselves as also restructured the acquired company's balance<br />

sheet. Dr Reddy's' buy-out of BMS Laboratories in UK has helped<br />

them scale up their European business to US$35-40mn range from<br />

target's business level of less than US$10mn in 2002. Wockhardt's<br />

acquisition of Wallace Labs and CP Pharmaceuticals in UK and<br />

Esparma in Germany has helped them build a strong profitable<br />

US$150mn+ European franchise and the total investment for these<br />

three buys was less than US$40 mn. Ranbaxy's success and early mover<br />

advantage in the key US market have been credited to their Ohm<br />

Pharma buy in the mid-nineties. Similar is the case of Sun Pharma with<br />

their Caraco acquisition in the US. Our discussions with Godrej Soaps<br />

indicate that things are moving well with their Keyline acquisition in<br />

UK.<br />

7<br />

It had not been roses all the way. Last year CNOOC<br />

withdrew its US$18.5bn bid for Unocal after pressure<br />

from US Congress. Similarly appliance manufacturer<br />

Haier withdrew its US$ 1bn+ bid for Maytag after<br />

facing opposition.<br />

Recently, Wall Street Journal in an article entitled<br />

"China <strong>Inc</strong>.'s Ambitions," poses the question of<br />

Wipro has been rumored to having had problems with their AMS' deal<br />

whether China could "buy a hefty chunk of Walof<br />

2002; but that did not stop the Company from aggressively pursuing<br />

Mart" and answers in the affirmative. According to<br />

other buy-out options and go ahead and do three deals worth $100mn+<br />

the article, such a purchase would be "a vertical<br />

in<br />

the last three months. Scandent seems to have successfully integrated<br />

integrator's dream" since if "Wal-Mart were a country,<br />

their Cambridge buy and is going ahead and merging their <strong>India</strong>n<br />

it would be China's eighth largest trading partner"<br />

company with their Mauritian holding company which includes the<br />

acquired business.<br />

Like inward FDI and foreign trade, is <strong>India</strong> lagging far<br />

behind China in outbound FDI? <strong>India</strong> gets only a<br />

tenth of what China gets in as inward foreign<br />

While the jury is still out on this question, all the available indications investment. For outbound foreign investment, <strong>India</strong>n<br />

are positive.<br />

levels are roughly half that of Chinese. So, is it just a<br />

catch up game for <strong>India</strong>? Can we think and act as<br />

aggressively as the Chinese? Could Wipro or HCL<br />

have bid for the IBM PC business? Could Tata<br />

Motors have bought MG Rover? Or will we find that<br />

it wasn't a commercial opportunity worth pursuing.


The Big Picture<br />

Which <strong>India</strong>n companies are buying?<br />

Is it that the first overseas deal is the most difficult one? Our study seems to indicate so. That probably explains the frequency of<br />

overseas deals by the same <strong>India</strong>n companies.<br />

Of the 244 deals we analyzed, 163 deals involved <strong>India</strong>n companies who have done more than one deal in the international context. Of<br />

the buyers, ONGC did a total of nine deals and Ranbaxy has done eight deals. The other main players are United Phosphorous (7<br />

deals), Wipro, Glenmark Pharma, 3i Infotech and Bharat Forge (5 deals each), Dr Reddy's. Amtek Auto, HCL Tech, Essel Propack,<br />

GAIL, Mahindra& Mahindra and Nicholas Piramal (4 deals each). Amongst the business groups, Tatas have been the most prolific<br />

buyer having bought assets in telecom (VSNL), tea, automotive, hotels and chemicals and invested close to US$ 1bn for global buys in<br />

2005. AV Birla <strong>Group</strong> has also been active having bought assets in copper mines, pulp mill and chemicals.<br />

Who are buying? Is it the <strong>India</strong>n market leader or are the small-mid cap companies also active in the international deal front? The<br />

experience differs widely across industries. In the pharma and auto sector, the <strong>India</strong>n market leaders have been in the forefront of<br />

global foray. However, this international outlook is not just confined to the big players. Mid sized companies in the pharma sector like<br />

Glenmark and Strides Arco have also done a fair amount of global buys. Coming to the software/BPO sector the market leaders have<br />

been reluctant to invest significantly for global deals. Tier II companies and even small-mid sized companies are more active than the<br />

leaders in this sector.<br />

Top overseas acquisitions by <strong>India</strong> <strong>Inc</strong><br />

Acquirer<br />

Target<br />

8<br />

Country<br />

Date<br />

Deal Size<br />

(US$mm)<br />

ONGC Greater Nile Oil Project Sudan Oct-02 766.1<br />

Dr. Reddy's Betapharm Arzneimittel GmbH Germany Feb-06 570.3<br />

Tata Tea Tetley <strong>Group</strong> UK Feb-00 431.2<br />

Ranbaxy Terapia SA (96.70% stak e) Romania Mar-06 324.0<br />

ONGC Sakhalin-1 PSA Project Russia Dec-00 323.0<br />

Videocon International Thomson SA (Cathode Ray Tube business) Europe, China Jun-05 289.2<br />

Tata Steel Natsteel Asia Pte ltd SE Asia Sep-03 283.7<br />

VSNL Teleglobe International Holdings USA Jul-05 254.3<br />

Matrix Docpharma NV Belgium Jun-05 234.7<br />

Reliance Gateway Net Flag Telecom USA Oct-03 191.2<br />

Tata Steel Millennium Steel pcl Thailand Dec-05 175.0<br />

Videocon International Thomson SA (Italian tube activity) Italy Jan-05 169.9<br />

Apeejay International Premier Foods plc (Tea Business) UK Oct-05 140.5<br />

ONGC 2 Sudanese Oil Interests Sudan Aug-03 136.5<br />

VSNL Tyco Global Network USA Nov-04 130.0<br />

Scandent Cambridge Services Holding USA Sep-05 120.0<br />

Tata Motors Tata Daewoo Commercial Vehicle Korea Nov-03 118.2<br />

United Phosphorus Advanta Netherlands Netherlands Feb-06 115.0<br />

Tata Chemicals Brunner Mond <strong>Group</strong> Plc UK Nov-05 111.2<br />

Essar Steel 2 Steel Mills UK Sep-05 100.4


What next?<br />

Will 2006 and beyond see a further rise in international deals by <strong>India</strong>n companies? The new found confidence of <strong>India</strong>n buyers<br />

supported by strong economy wide fundamentals seems to suggest so.<br />

Most of the out-bound deals so far have been limited in scope and size; we foresee a trend of large deals going forward. While it maybe<br />

sometime before we see <strong>India</strong>n transformational deals similar to Chinese company Lenovo's purchase of IBM's PC business, we<br />

believe <strong>India</strong>n companies are increasingly bidding for large significant assets abroad. Case in point is Dr Reddy's purchase of<br />

Betapharm and Ranbaxy's purchase of Terapia in Q1-2006. Media reports indicated that Wockhardt was seriously in the race for large<br />

companies (around US$1bn in value) in the US. We believe it is just a matter of time before we see more large outbound deals from<br />

<strong>India</strong>.<br />

Who will do these deals? The big players or the small to medium sized ones? Across industries or only in some selected sectors? We<br />

believe that the deal street will continue to be hot for global industries like pharma and auto components. A new trend that would<br />

emerge could be for manufacturing companies especially in the small to medium sector. There could be significant value creation<br />

opportunities for <strong>India</strong>n buyers to acquire manufacturing companies in developed markets and then try and restructure the<br />

manufacturing model by either offshoring some/all of the production activities or by plugging into <strong>India</strong> costs. If this trend catches up,<br />

this could cut across industries as exemplified by Crompton Greaves' purchase of Pauwells transformer business or Essel Propack's<br />

buys in UK, US and Singapore.<br />

9


THE INDUSTRY CONTEXT<br />

Automotives Sector<br />

The Automotives sector includes both Automobiles and Auto component companies. It accounted for 9.8% of total deal volume and<br />

5% of deal value.<br />

Tata Motor's acquisition of Korea based Daewoo Commercial Vehicles is the biggest overseas acquisition in the sector. In Nov 2003,<br />

Tata's bought 100% of this truck company for US$118.2mn which had annual sales of about US$ 250mn. Tatas have subsequently<br />

bought auto design companies in UK and Germany and autopart companies in Spain and Germany. Amtek Auto bought four<br />

companies in the last four years in the forgings and components business, though most of these buys were in the


The Industry Context<br />

Chemicals & Fertilizers<br />

The Chemical & Fertilizers sector includes chemical, agrichemical and industrial chemical companies. It accounts for 7% of total deal<br />

volume and 7.7% of total deal value<br />

Value (US$mm)<br />

500<br />

400<br />

300<br />

200<br />

100<br />

0<br />

2000 2001 2002 2003 2004 2005 Q106<br />

Source: Bloomberg, Merger Markets, Mape<br />

Tata Chemicals' acquisition of Brunner Mond <strong>Group</strong> plc Nov -05 for US$111mn is the biggest deal in the sector. Deal activity has<br />

gained momentum since 2005 with Tata Chemicals, United Phosphorus & Asian Paints making bulk of the acquisitions in the sector.<br />

Sector has witnessed acquisitions in Sri Lanka, Australia, South Africa apart from Europe and North America. Big players like Tata<br />

Chemicals have shown interest to acquire more firms overseas. Tatas lost a bid to acquire a large fertilizer company in Egypt in May-05.<br />

Select Transactions in the Sector<br />

Acquirer<br />

Asian Paints<br />

Target<br />

SCIB Chemicals SAE<br />

Country<br />

Egypt<br />

Value No of Deals<br />

Date<br />

Aug-02<br />

11<br />

Deal Size<br />

(US$mn)<br />

GHCL SC Bega Upsom Romania Dec-05 19.5<br />

Tata<br />

Chemicals<br />

Tata<br />

Chemicals<br />

United<br />

Phosphorus<br />

United<br />

Phosphorus<br />

United<br />

Phosphorus<br />

United<br />

Phosphorus<br />

Indo Maroc<br />

Phosphore SA<br />

Brunner Mond<br />

<strong>Group</strong> Plc<br />

Oryzalin Herbicide<br />

Operations<br />

AG Value <strong>Inc</strong>.<br />

Cequisa<br />

Reposo SAIC<br />

Morocco<br />

UK<br />

USA<br />

USA<br />

Spain<br />

Argentina<br />

Mar-05<br />

Nov-05<br />

5.1<br />

38.0<br />

111.2<br />

Jun-03 21.3<br />

Nov-04<br />

Jun-05<br />

Oct-05<br />

35.8<br />

14.1<br />

11.0<br />

8<br />

6<br />

4<br />

2<br />

0<br />

No. of Deals<br />

Stake / Remarks<br />

60% in Egypt based company with annual<br />

turnover of US$12.0mn<br />

65% in the Romanian soda ash manufacturer<br />

100% in Indo Maroc was a JV between<br />

Kingdom of Morocco & Chambal Fertilizers<br />

63.5% in the UK based chemical company<br />

100% in oryzalin herbicide business of Dow<br />

Agroscience<br />

100% in the US based company having an<br />

annual turnover of US$53.2mn<br />

100% in the Spanish company having annual<br />

revenues of US$23.5mn<br />

100.0% in the Argentinean company with<br />

annual revenues of US$12.5mn


The Industry Context<br />

Consumer Sector<br />

The Consumer sector comprises deals made in the Tea, Apparel and Textile. The Consumer sector accounts for 4.1% of total deal<br />

volume and 7.8% of deal value.<br />

Value (US$mm)<br />

500<br />

400<br />

300<br />

200<br />

100<br />

0<br />

2000 2001 2002 2003 2004 2005 Q106<br />

Source: Bloomberg, Merger Markets, Mape<br />

Value No of Deals<br />

Two tea deals (Tata-Tetley and Apeejay - Premier Foods) accounted for 87% of total deal value in the sector. Tata Tea's acquisition of<br />

Tetley group for US$431.2mn is the biggest deal in the sector and is considered as a landmark deal for outbound <strong>India</strong>n transactions.<br />

Godrej's recent acquisition of Keyline Brands in the UK is the first instance of an <strong>India</strong>n company buying a foreign business on standalone<br />

basis rather than as a synergy/front- end for the <strong>India</strong>n activities as in the case of tea industry deals.<br />

The increasing prominence of <strong>India</strong>n textile companies in the international market place has not mirrored in their deal activity. We<br />

foresee heightened international deal activity in this sector driven by <strong>India</strong>n companies' quest for customer relationships and global<br />

production facilities.<br />

Select Transactions in the Sector<br />

Acquirer Target<br />

Country<br />

Date Deal Size<br />

(US$mn)<br />

Apeejay Premier Foods lpc UK Oct-05 140.5 1 0% in th list e de UK foo compa d yn<br />

Int renational (T ae Bsuiness)<br />

Dabur I dnia Redrock Lt .d UK Jul-03 5.0 UK base dR derock is engag de in<br />

manufacturi gn, selling, incl duing export of<br />

vario su cosm teics, toiletries a dn healthcare<br />

products GHCL Dan iRver Icn. USA Dec-05 53.5 100% in US- absed manufacturer and<br />

marketer of textil eproducts Godrej Keyline Brands Ltd UK Oct-05 2 .2 100% in UK based FMCG company eng gaed<br />

in t eh manuf cature, marketing, sales a d n<br />

distributio nof c som etics and toiletries;<br />

annual turnover of GBP16.7mn in 2004<br />

Raymond <strong>India</strong> Regency Tex tiles Portuguese Oct-01 3.0 100% in the Portugal-based garments Portug ea su<br />

company<br />

Tata Tea Tetl y <strong>Group</strong> e<br />

UK eFb-0 431.2 100% in th eworld's N muber tea 2 bag<br />

company, with a pr senec ei nover 35<br />

co nutries<br />

Tata Tae Fmal herb I cn. & USA Oct-05 Est. < 10.0 100% in Califor ina-based c mo panies selling<br />

Goodearth herbal, fruit flavore d , medicinal and<br />

traditional t aes<br />

Remarks<br />

12<br />

6<br />

5<br />

4<br />

3<br />

2<br />

1<br />

0<br />

No. of Deals


The Industry Context<br />

Healthcare Sector<br />

The Healthcare sector comprises companies in the Pharmaceutical, Healthcare, Life sciences and Biotech space. It has been next only<br />

to the IT sector in terms of deal volume at 20.5%. It also accounts for 18.8% of deals by value.<br />

Value (US$mm)<br />

1000<br />

800<br />

600<br />

400<br />

200<br />

0<br />

Source: Bloomberg, Merger Markets, Mape<br />

2000 2001 2002 2003 2004 2005 Q106<br />

The healthcare sector witnessed a surge of activity in 2005 with 26 overseas deals. The first three months of 2006 has witnessed two of<br />

the biggest deals in the sector; Dr. Reddy's acquiring Betapharm for US$570.3mn and Ranbaxy acquiring Terapia for US$324mn. More<br />

than 90% of the acquisitions in this sector have been made in Europe and North America.<br />

The highly regulated developed economies of Europe and US are becoming the key market for most <strong>India</strong>n companies with increasing<br />

generic push in these markets. Most companies in the sector have made their overseas ambitions clear by declaring intentions to acquire<br />

more firms and we expect a fair amount of large cross border deals in this sector. Also, regulatory requirements of market access will<br />

see a host of small sized deals in different markets as in the case of Glenmark Pharma. Given the increasing importance of <strong>India</strong> as a<br />

base for clinical trials, we foresee more deals in this sector similar to Jubilant's buy-out of Target and Dishman's various deals.<br />

Select Transactions in the Sector<br />

Value No of Deals<br />

Acquirer Target Country Date Deal Size<br />

(US$mn)<br />

Dr. Reddy's API Business of<br />

Roche<br />

Dr. Reddy's Betapharm<br />

Arzneimittel GmbH<br />

Jubilant Target Research<br />

Associates<br />

13<br />

30<br />

25<br />

20<br />

15<br />

10<br />

5<br />

0<br />

Remarks<br />

Mexico Nov-05 59.0 100% in API business at Mexico including all<br />

employees and business supply contracts<br />

Germany Feb-06 570.3 100% in the fourth largest generic drug Co in<br />

Germany; annual turnover of US$195.2mn;<br />

USA Oct-05 33.5 100% in the US based full service Clinical<br />

Research Organization (CRO)<br />

Matrix Docpharma NV Belgium Jun-05 234.7 95.5% in the listed Belgium based generic<br />

company<br />

Ranbaxy RPG AVENTIS SA France Dec-03 80.0 100% in the French company ranked fifth in<br />

generic market with a 6% market share;<br />

Ranbaxy Terapia SA (96.70%<br />

stake)<br />

No. of Deals<br />

annual sales of EUR52.0mn<br />

Romania Mar-06 324.0 96.7% stake in Romania based company<br />

having annual turnover of US$80.0mn<br />

Sun<br />

Pharmaceutical Caraco USA Mar-04 Est. < 50.0 63.1% in Detroit-based company<br />

CP<br />

100% in the UK based company; annual<br />

Wockhardt Pharmaceuticals UK Jul-03 17.7 turnover of US$56.1mn


The Industry Context<br />

Software / BPO Sector<br />

Software/BPO sector has been an avid shopper in the international market place and accounted for 33.6% of all overseas acquisition<br />

by volume though by deal size the share was only 13% implying a large amount of smaller deals.<br />

Value (US$mm)<br />

500<br />

400<br />

300<br />

200<br />

100<br />

0<br />

2000 2001 2002 2003 2004 2005 Q106<br />

Source: Bloomberg, Merger Markets, Mape<br />

Small players have been more active than big names like Wipro, Infosys and TCS. In fact given the size and global standing of <strong>India</strong>n<br />

software companies, there have not been many significant transactions in this sector. The sector saw a host of cross border deals in<br />

2000 during the height of the tech boom; though the deal activity tapered off after that. Also, the sector has a few companies that are<br />

founded /statured on foreign acquisitions - 3i Infotech and Scandent Solutions. Patni's buy-out of Cymbal at US$67mn and Wipro's<br />

buy-out of Newlogic for US$56mn are the two largest deals in the software space. In the BPO space, Scandent's Cambridge buy and<br />

WNS' purchase of the US mortgage BPO - Trinity Partners - are the most significant deals. Sector also saw a few "large" ($50-100mn<br />

range) buy-outs in 2000 predominantly through stock transactions by <strong>India</strong>n companies, though the current market equivalent valuation<br />

of most of these stock deals will be less than US$5mn.<br />

Here again, buying of foreign businesses and offshoring the work while keeping the front-end intact has been a recurrent them for<br />

value creation possibilities. Except of HCL Tech which pursued this path for a few smaller deals, most of the large companies have<br />

stayed clear of this. An interesting point is that in-bound cross border deals have been at significant level with global majors like IBM,<br />

EDS, Oracle etc buying up significant assets in <strong>India</strong>. <strong>India</strong>n companies who are already global or have global ambitions are still to<br />

invest abroad in a significant manner. Is it that <strong>India</strong>n companies are reluctant to be aggressive or is that the evolving structure of the<br />

industry is such that <strong>India</strong> is the place to be in? Jury is still out.<br />

Select Transactions in the Sector<br />

Value No of Deals<br />

Acquirer Target Country Date Deal Size<br />

(US$mn)<br />

Patni<br />

Computer<br />

Satyam<br />

Computer<br />

Scandent Cambridge<br />

Services Holding<br />

Tata<br />

Consultancy<br />

Wipro Newlogic<br />

Technologies<br />

14<br />

Remarks<br />

Cymbal Corp USA Oct-04 68.0 100% in California based IT firm; Annual<br />

turnover of US$32mn<br />

Citisoft UK Apr-05 23.2 100% in European business and systems<br />

consulting firm<br />

USA Sep-05 120.0 75% in US based BPO business with sales of<br />

US$300mn and EBITDA of US$30mn<br />

ComiCrom Chile Nov-05 23.0 100% of Chile based IT firm; 1257<br />

employees; Annual revenues of US$35.5mn<br />

Austria Dec-05 56.4 100% in Austria based Bluetooth and<br />

Wireless LAN design firm<br />

WNS Global<br />

Servies Trinity Partners USA Nov-05 63.0<br />

30<br />

25<br />

20<br />

15<br />

10<br />

5<br />

0<br />

No. of Deals<br />

100% in Arizona-based mortgage BPO<br />

player


The Industry Context<br />

Metals & Mining Sector<br />

Metals & Mining sector accounted for 4.5% of total deal volume and 11.3% of deal value implying a fewer number of large deals.<br />

Value (US$mm)<br />

600<br />

500<br />

400<br />

300<br />

200<br />

100<br />

0<br />

2000 2001 2002 2003 2004 2005 Q106<br />

Overseas acquisitions have been largely made in Australia (50%) and SE Asia (25%). Average deal size is US$88.2mn. Tata steel's<br />

acquisition of Millennium Steel for US$398.5mn is the biggest deal in the sector. <strong>India</strong>n companies have shopped abroad for both<br />

reasons - access to captive raw material sources and for production capacity in other markets. <strong>Inc</strong>reasing global stature of <strong>India</strong>n mining<br />

companies will mean increased global deal activity - both for captive raw materials and globalizing their production capacity.<br />

Select Transactions in the Sector<br />

Source: Bloomberg, Merger Markets, Mape<br />

Value No of Deals<br />

Acquirer Target Country Date Deal Size<br />

(US$mn)<br />

15<br />

Remarks<br />

Essar Steel 2 Steel Mills UK Sep-05 100.4 100% in Hy-Grade Pellets (HGPL) and Steel Corporation<br />

of Gujarat (SCGL) from Stemcor, UK<br />

Hindalco Mount Gordon<br />

copper mine<br />

Hindalco Nifty Copper<br />

ops<br />

Tata Steel Natsteel Asia<br />

Pte ltd<br />

Tat a Steel Carborough<br />

downs coal<br />

project<br />

Tata Steel Millennium<br />

Steel<br />

Australia Jan-03 14.3 100% in the Australian copper mines from Western<br />

metals Ltd<br />

Australia Oct-05 94.0 50% interest in Maroochydore exploration project from<br />

Straits Resources Limited, the listed Australian mining<br />

company. Concurrently Hindalco acquired Straits<br />

6<br />

5<br />

4<br />

3<br />

2<br />

1<br />

0<br />

No. of Deals<br />

(Nifty) Pty Ltd., from Straits<br />

SE Asia Sep-03 283.7 100% in the Singapore based company which owns<br />

steel mills in China, Thailand, Vietnam, Philippines<br />

and Australia, with a capacity of 2.0mntpa; 26% per<br />

cent equity in Southern Steel Berhad, a 1.3mntpa steel<br />

maker in Malaysia<br />

Australia Jul-05 Est. < 5.0 5% interest in the Carborough Downs coal project<br />

located in Queensland<br />

Thailand Dec-05 398.5 100% in Thailand based company having a capacity of<br />

1.7mntpa producing long products for construction and<br />

engineering steel for auto industries. It has three<br />

operating facilities in Saraburi, Rayong and Chonburi<br />

province


The Industry Context<br />

Oil & Gas Sector<br />

Oil & Gas sector accounts for 5.3% of total deal volume and nearly 18.6% of deal value.<br />

Value (US$mm)<br />

900<br />

800<br />

700<br />

600<br />

500<br />

400<br />

300<br />

200<br />

100<br />

0<br />

2000 2001 2002 2003 2004 2005 Q106<br />

Source: Bloomberg, Merger Markets, Mape<br />

GAIL & ONGC account for all the deals made in the sector. Average deal size in the sector is US$122.1mn, far above the average of<br />

US$35.1mn.<br />

Hydro-carbon business is essentially global in nature that all the big players have traditionally been global rather than local. ONGC's<br />

significant foray into international markets signals its transformation from a large domestic player to an emerging global player. ONGC<br />

is expected to continue its foray in international markets with a view to securing equity oil.<br />

Future deals can be expected from downstream players like <strong>India</strong>n Oil Corporation<br />

Select Transactions in the Sector<br />

Value No of Deals<br />

Acquirer Target Country Date Deal Size<br />

(US$mn)<br />

Remarks<br />

Gail <strong>India</strong> Fayum Gas Co. Egypt Jan-04 9.7 19% in the Egypt based city gas<br />

distribution company<br />

Gail <strong>India</strong> NATGas Egypt Aug-04 19.0 15% in Egypt based natural Gas company<br />

Gail <strong>India</strong> China Gas Holdings Ltd. China Feb-05 31.0 10% stake in the Chinese company<br />

ONGC Sakhalin-1 PSA Project Russia Dec-00 323.0 100% in the Sakhalin project from OAO<br />

Rpsneft Oil Company<br />

ONGC Greater Nile Oil Project Sudan Oct-02 766.1 25% in the project from Talisman Energy<br />

Co<br />

ONGC 2 Sudanese Oil Interests Sudan Aug-03 136.5 100% interest in assets from OMV AG<br />

16<br />

6<br />

5<br />

4<br />

3<br />

2<br />

1<br />

0<br />

No. of Deals


The Industry Context<br />

Other Sectors<br />

Overview<br />

All other deals which have not been covered separately above have been accounted for in this category. In a broad measure they include<br />

deals made in the Telecom & Media, Financial Institutions & Banking, Power & Utility, Packaging and Manufacturing space. All these<br />

sectors put together account for 15.2% of total deal volume and 17.8% of total deal value.<br />

Telecom (35.2%) and Packaging (8.6%) account for nearly 43.8% of deals made in the sector on value basis. Average deal size is<br />

US$41.2mn. VSNL's acquisition of US based Teleglobe International for US$254.3mn and Reliance's acquisition of Flag Telecom for<br />

US$191.2mn are the biggest deals in this category.<br />

Acquirer Target Country Date Deal Size<br />

(US$mn)<br />

17<br />

Remarks<br />

Apollo Tyres Dunlop Tyres South Africa Jan-06 62.0 100% in the South Africa based company<br />

producing bias and radial products; annual<br />

turnover of US$210mn in CY2005<br />

Crompton<br />

Greaves<br />

Reliance<br />

Gateway Net<br />

Reliance<br />

Industries<br />

United<br />

Phosphorus<br />

Videocon<br />

International<br />

Value (US$mm)<br />

1200<br />

1000<br />

800<br />

600<br />

400<br />

200<br />

Select Transactions in the Sector<br />

0<br />

Source: Bloomberg, Merger Markets, Mape<br />

Pauwels Tr ansformer<br />

business<br />

Belgium Feb-05 42.5 100% in Belgium based manufacturer of<br />

three-phase transformers<br />

Flag Telecom USA Oct-03 191.2 100% in the US company which has laid<br />

submarine cables of around 50,000 km<br />

across the globe and has hubs in Middle<br />

East and the United States<br />

Trevira GmbH Germany Jun-04 97.4 100% in German based manufacturers of<br />

polyester fibres and filament yarns; Annual<br />

turnover of EUR316mn in 2003<br />

Advanta Netherlands Netherlands Feb-06<br />

115.0 100.0% in the seed business of Advanta<br />

group; annual turnover of US$ 74.5mn<br />

Thomson SA (Italian<br />

tube activity)<br />

2000 2001 2002 2003 2004 2005 Q106<br />

Value No of Deals<br />

Italy Jan-05 169.9 No details available<br />

VSNL Tyco Global Network USA Nov-04 130.0 No details available<br />

VSNL<br />

Teleglobe<br />

International Holdings USA Jul-05 254.3<br />

20<br />

15<br />

10<br />

5<br />

0<br />

No. of Deals<br />

100% in US based telecoms network<br />

services company


TH E DEAL DETAILS<br />

Automotives Sector<br />

Acquirer Target Country Date Deal Size Remarks<br />

Amtek Auto Smith Jones <strong>Inc</strong> USA Dec-02 7.4 100% buyout of Iowa based manufacturer of flywheel ring<br />

gears and flex plates<br />

Amtek Auto GWK Amtek Ltd. UK Jul-03 10.7 85% stake in UK based manufacturer of vehicle parts and<br />

components and holding company of King Automotive<br />

Systems Ltd. and Geo W King Ltd<br />

Amtek Auto Zelter GmbH Germany Jul-05 Est. < 5.0 70% stake in Germany based manufacturer of machined turbo<br />

charger housings<br />

Amtek Auto Tyco International<br />

(Forgings Business)<br />

Bharat Forge Carl Dan Peddinghus<br />

GmbH<br />

Bharat Forge CDP AluminTechnik<br />

GmbH<br />

Bermuda Jan-06 5.0 100% stake in forgings plant which has an annual capacity of<br />

30-35ktpa<br />

Germany Nov-03 33.9 100% acquisition of German based company having an annual<br />

turnover of US$142mn in an asset purchase deal<br />

Germany Dec-04 8.3 100% acquisition of Germany based aluminum forge<br />

components manufacturer having an annual turnover of<br />

US$42.7mn<br />

Bharat Forge Federal Forge <strong>Inc</strong> USA Jun-05 9.1 100% stake in US based company which had filed for<br />

protection under Chapter 11 of the U.S. Bankruptcy Code<br />

Bharat Forge Imatra Kilsta AB Sweden Sep-05 61.0 100% stake in front axle beams and crankshafts manufacturer<br />

having an annual turnover of about US$132mn in 2004<br />

Bharat Forge FAW <strong>Group</strong> China Dec-05 Est. < 5.0 Acquired stake in a JV with China's largest automotive group<br />

Eicher Motors Design Intent<br />

Engineering <strong>Inc</strong>.<br />

USA Jun-05 2.5 100% stake in Detroit based engineering services provider<br />

having several leading OEMs and Tier-1 manufacturers as its<br />

customers<br />

18


The Deal Details<br />

Automotives Sector contd.<br />

Acquirer Target Country Date Deal Size Remarks<br />

Escorts Farmtrac Tractors<br />

Europe SP<br />

Poland Mar-05 Est. < 10.0 No details available<br />

Mahindra & Mahindra Tractor Making Unit China Nov-04 8.0 80% stake in a JV with Jiangling <strong>Group</strong> of China to acquire<br />

Jiangling's tractor unit<br />

Mahindra & Mahindra Tractorul Utb Romania Sep-05 Est. < 50.0 Acquired the listed Romania based tractor manufacturer<br />

having an annual turnover of US$51.8mn in 2004<br />

Mahindra & Mahindra Stokes <strong>Group</strong> Ltd. UK Jan-06 12.5 100% stake in UK based automotive forging company; Annual<br />

turnover of GBP25.0mn<br />

Sona Koyo Steering Fuji Autotech France<br />

SAS<br />

France Oct-04 6.2 21.05% stake in a French company that makes steering<br />

columns<br />

Sundaram Fasteners Precision Forge Unit UK Nov-03 2.5 100% acquisition of the precision forge unit of UK based Dana<br />

Spicer Ltd<br />

Sundaram Fasteners Bleistahl Produktions<br />

GmbH<br />

Sundaram Fasteners Peiner Umformtechnik<br />

GmbH<br />

Germany Oct-04 Est. < 10.0 76% stake in a JV to make valve train parts, including valve<br />

guides and valve seats<br />

Germany Nov-05 13.8 100% stake in Germany based manufactures of fastener<br />

products for the automobile, industrial and construction<br />

sectors<br />

Tata Autocomp Wundsch Weidinger Germany Aug-05 4.9 100% stake in German automotive company producing plastic<br />

parts and systems for the automobile industry<br />

Tata Motors Tata Daewoo<br />

Commercial Vehicle<br />

Korea Nov-03 118.2 100% buyout of the Korean truck company having annual<br />

turnover of US$250mn<br />

Tata Motors Hispano Carrocera SA Spain Feb-05 15.9 21% stake in Hispano of Spain<br />

Tata Motors <strong>Inc</strong>at International Plc UK Aug-05 90.3 100% stake in UK based design company having 650<br />

enployees; Sales of EUR65.3mn and operating profit of<br />

Tata Motors Cedis Mechanical<br />

Engineering<br />

EUR2.4mn in YE2004<br />

Germany Jan-06 Est. < 5.0 100% stake in Germany-based provider of automotive<br />

engineering and design services<br />

TVS Autolec RBI Autoparts SDN BHD Malaysia Feb-04 Est. < 10.0 40% stake in the Malaysian autoparts company<br />

19


The Deal Details<br />

Chemicals & Fertilizers Sector<br />

Acquirer Target Country Date Deal Size Remarks<br />

Aditya Birla Dashiqiao Chem, China China Aug-05 8.5 No details available<br />

Asian Paints Delmege Forsyth Sri Lanka Oct-99 Est. < 5.0 76% stake in a Sri Lankan company with annual turnover of<br />

US$3.5mn<br />

Asian Paints Pacific Paints Co Pte<br />

Ltd.<br />

Australia Nov-00 0.2 No details available<br />

Asian Paints SCIB Chemicals SAE Egypt Aug-02 5.1 60% stake in Egypt based company with annual turnover of<br />

US$12.0mn<br />

Asian Paints Taubman Paints<br />

Limited<br />

Fiji Sep-03 1.5 100% stake in Fiji's fourth largest paint maker<br />

GHCL SC Bega Upsom Romania Dec-05 19.5 65% stake in the Romanian soda ash manufacturer<br />

Tata Chemicals Indo Maroc Phosphore<br />

SA<br />

Tata Chemicals Brunner Mond <strong>Group</strong><br />

Plc<br />

United Phosphorus Oryzalin Herbicide<br />

Operations<br />

United Phosphorus BASF Aciflorfen<br />

Business<br />

United Phosphorus Cropserve South Africa<br />

Morocco Mar-05 38.0 100% stake in Indo Maroc ; Target was a JV between Kingdom<br />

of Morocco & Chambal Fertilizers<br />

UK Nov-05 111.2 63.5% stake in the UK based chemical company<br />

USA Jun-03 21.3 100% stake in oryzalin herbicide business of Dow Agroscience<br />

USA, Brazil Sep-03 Est. < 5.0 100% stake in Acifluorfen, a herbicide active ingredient from<br />

BASF<br />

Mar-04 Est. < 5.0 20% stake in stake in South Africa based company which has<br />

an annual turnover of US$122.0mn<br />

United Phosphorus AG Value <strong>Inc</strong>. USA Nov-04 35.8 100% stake in the US based company; Target sales of<br />

US$53.2mn<br />

United Phosphorus Cequisa Spain Jun-05 14.1 100% stake in the Spanish company; Target sales of<br />

US$23.5mn<br />

United Phosphorus Reposo SAIC Argentina Oct-05 11.0 100% stake in the Argentinanean company; Target sales of<br />

US$12.5mn<br />

Vishnu Chemicals DTLL <strong>Inc</strong>. USA Sep-02 1.4 No details available<br />

20


The Deal Details<br />

Consumer Sector<br />

Acquirer Target Country Date Deal Size Remarks<br />

Apeejay<br />

International<br />

Bhartiya<br />

International<br />

Premier Foods plc (Tea<br />

Business)<br />

UK Oct-05 140.5 100% stake in the listed UK food company<br />

Ompel SPA Milan May-03 1.5 100% stake in Milan-based international leather and<br />

outerwear apparel company<br />

Dabur <strong>India</strong> Redrock Ltd. UK Jul-03 5.0 UK based Redrock is engaged in manufacturing, selling,<br />

including export of various cosmetics, toiletries and<br />

healthcare products<br />

GHCL Dan River <strong>Inc</strong>. USA Dec-05 53.5 100% stake in US-based manufacturer and marketer of textile<br />

products<br />

Godrej Keyline Brands Ltd UK Oct-05 22.2 100% stake in UK based FMCG company engaged in cosmetics<br />

and toiletries; Target sales of GBP16.7mn in 2004<br />

Malwa Industries Third Dimension<br />

Apparel<br />

N/A Jun-05 6.5 No details available<br />

Marico Industries Sundari LLC USA Feb-03 Est. < 5.0 Purchase of luxury ayurvedic skincare products (sales<br />

US$1.1mn)<br />

Marico Industries Aromatic Cosmetics Bangladesh Oct –05 Est. < 5.0 Purchase of toilet soap brand to beef up its Bangladesh<br />

franshise<br />

Raymond <strong>India</strong> Regency Textiles<br />

Portuguesa<br />

Portuguese Oct-01 3.0 100% stake in the Portugal-based garments company<br />

Tata Tea Tetley <strong>Group</strong> UK Feb-00 431.2 100% stake in the world's Number 2 tea bag company, with a<br />

presence in over 35 countries<br />

Tata Tea Fmal herb <strong>Inc</strong>. &<br />

Goodearth<br />

USA Oct-05 Est. < 10.0 100% stake in California-based companies selling herbal, fruit<br />

flavored, medicinal and traditional teas<br />

21


The Deal Details<br />

Healthcare Sector<br />

Acquirer Target Country Date Deal Size Remarks<br />

Aurobindo Pharma Milpharm Ltd Europe Feb-06 Est. < 5.0 100% stake in UK based generic formulation pharmaceutical<br />

company<br />

Cadila Alpharma SAS France Jul-03 6.2 100% of the formulation business of Alpharma<br />

Dishman<br />

Pharmaceuticals<br />

Dishman<br />

Pharmaceuticals<br />

Synprotec Ltd UK Apr-05 3.8 100% stake in UK based company having a track record of<br />

more than 20 years of customer relationships with pharma<br />

and chemical multinationals through its strong market<br />

presence in Europe and the US<br />

I03S Switzerland Dec-05 Est. < 5.0 100% stake in Switzerland based contract research company<br />

Dr. Reddy's BMS Laboratories UK Mar-02 12.8 100% stake in UK based Company; annual turnover of<br />

GBP8.0mn and profit after tax of GBP1.6mn in 2001<br />

Dr. Reddy's Trigenesis Therapeutics<br />

<strong>Inc</strong><br />

USA May-04 11.0 100% stake in a US based privately owned dermatology<br />

Company<br />

Dr. Reddy's API Business of Roche Mexico Nov-05 59.0 100% stake in API business at Mexico including all employees<br />

and business supply contracts<br />

Dr. Reddy's Betapharm<br />

Arzneimittel GmbH<br />

Glenmark Laboratorios Klinger Do<br />

Bras<br />

Glenmark Uni-Ciclo Harmonial<br />

Brand<br />

Germany Feb-06 570.3 100% stake in the fourth largest generic drug Co in Germany;<br />

annual turnover of US$195.2mn; largest acquisition by an<br />

<strong>India</strong>n pharma firm.<br />

Brazil Apr-04 5.2 100% stake in the Brazilian company with expected revenues<br />

of US$7.0mn<br />

Brazil Mar-05 4.6 100% buyout of a leading hormonal brand with sales of<br />

US$3.1mn.<br />

Glenmark Servycal SA Argentina Oct-05 Est. < 5.0 100% stake in the Argentine marketing company<br />

Glenmark 2 FDA products from<br />

Clonmel Healthcare<br />

Ireland Dec-05 Est. < 5.0 100% stake in two FDA approved products from Clonmel<br />

Healthcare Ltd; market-size for the products is<br />

approximately US$50mn and has limited generic competition<br />

22


The Deal Details<br />

Healthcare Sector contd.<br />

Acquirer Target Country Date Deal Size Remarks<br />

Glenmark Bouwer Bartlett Pty<br />

Ltd<br />

South<br />

Africa<br />

Dec-05 Est. < 5.0 100% stake in a South African sales and marketing company<br />

Hikal Marsing & Co AS Denmark Sep-04 6.0 50.1% stake in a Danish pharmaceutical marketing and<br />

distribution company with annual turnover of US$60.0mn<br />

Indegene Lifesystems Medsn <strong>Inc</strong> USA Sep-05 7.0 100% stake in US based provider of training and marketing<br />

services to the healthcare industry<br />

Jubilant PSI Supply NV Belgium Jun-04 16.5 80% stake in the Belgium based company; annual sales of<br />

EUR9.6mn in YE Mar 2004<br />

Jubilant Trinity Laboratories <strong>Inc</strong> USA Jul-05 12.3 64% stake in the US-based generic pharmaceuticals company<br />

Jubilant Ta rget Research<br />

Associates<br />

Kemwell Private<br />

Limited<br />

Pfizer Health AB<br />

(manufacturing plant<br />

in Uppsala, Sweden)<br />

USA Oct-05 33.5 100% stake in the US based full service Clinical Research<br />

Organization<br />

Sweden Feb-06 Est. < 5.0 100% stake in Uppsala a Sweden situated API and unfinished<br />

drugs manufacturing facility from Pfizer Health<br />

Matrix MCHEM Pharma <strong>Group</strong> China Feb-05 Est. < 5.0 60% stake in the China based company manufacturing fine<br />

chemicals, active pharmaceutical ingredients and<br />

formulations; annual turnover of ~US$35.0mn<br />

Matrix Docpharma NV Belgium Jun-05 234.7 95.5% stake in the listed Belgium based generic company<br />

Matrix Explora Laboratories SA Switzerland<br />

Sep-05 Est. < 5.0 43% stake in the technology platform company based in<br />

Mendrisio, Switzerland<br />

Max <strong>India</strong> Altacast LLC USA Apr-00 7.0 22% stake in the US based holding company of `HealthCast'<br />

an advanced healthcare solutions company dedicated to<br />

improving access to critical patient car<br />

Max <strong>India</strong> Mindcrossing USA Apr-00 4.0 15% stake in US based company which provides infrastructure<br />

for rapid development of portals and exchanges<br />

Natco Pharma Nick’s Drug Store USA Jan –06 Est. < 5.0 75% purchase of a New Jersey drug store with $20mn<br />

revenues<br />

23


The Deal Details<br />

Healthcare Sector contd.<br />

Acquirer Target Country Date Deal Size Remarks<br />

Nicholas Piramal Dobutrex Brand Rights USA Jul-04 Est. < 5.0 100% rights of Dobutrex Brand in <strong>India</strong> from Eli Lily &<br />

Company, USA<br />

Nicholas Piramal Anaesthetics business<br />

in UK<br />

UK Dec-04 14.0 100% of Rhodia’s global Inhalation Anaesthetics business<br />

based in UK<br />

Nicholas Piramal Biosyntech <strong>Inc</strong>. Canada Jul-05 4.1 17.1% stake in the Canadian biotech research company<br />

BioSyntech<br />

Nicholas Piramal Avecia Pharmaceuticals UK Oct-05 16.9 100% stake in the UK-based CMO having annual turnover of<br />

US$64.2mn<br />

Opto Circuits Medical Equipment Co. Europe Oct-05 13.3 100% stake in the US based company which is developing a<br />

novel blood glucose monitoring machine<br />

Opto Circuits Eurocor GmbH Germany Dec-05 13.0 100% stake in the German company that designs and<br />

manufactures stents<br />

Ranbaxy Bayer's Generic Drug<br />

business<br />

Germany Apr-00 Est. < 5.0 No Details available<br />

Ranbaxy Veratide Germany Jun-02 Est. < 5.0 100% of Veratide - the anti-hypertensive brand in Germany<br />

from P&G<br />

Ranbaxy Signature Pharma's<br />

Liquid manufacturing<br />

unit<br />

USA Jul-02 Est. < 5.0 100% of a liquid manufacturing facility from the New Yorkbased<br />

Signature Pharmaceuticals <strong>Inc</strong> on an asset-purchase<br />

basis<br />

Ranbaxy RPG AVENTIS SA France Dec-03 80.0 100% stake in the French company ranked fifth in generic<br />

market with a 6% market share; annual sales of EUR52.0mn<br />

Ranbaxy Efarmes - generic<br />

product<br />

Ranbaxy Terapia SA (96.70%<br />

stake)<br />

Spain Jun-05 Est. < 5.0 100% stake in a generic product portfolio accounting for<br />

eighteen products belonging to the Spanish pharmaceutical<br />

company EFARMES<br />

Romania Mar-06 324.0 96.7% stake in Romania based company having annual<br />

turnover of US$80.0mn<br />

Ranbaxy Allen SpA Italy Mar-06 Est. < 10.0 Purchase of Glaxo’s unbranded Italian generic business<br />

Ranbaxy Ethimed, Belgium Belgium Mar-06 Est. < 10.0 100% stake in a Belgian generic pharmaceutical distributor<br />

24


The Deal Details<br />

Healthcare Sector contd.<br />

Acquirer Target Country Date Deal Size Remarks<br />

Shantha Biotech East West Labs <strong>Inc</strong> USA Sep-00 Est. < 10.0 No details available<br />

Shasun Chemicals RHODIA, FRANCE -<br />

Custom Synthesis<br />

business<br />

France Apr-06 Est. < 5.0 100% stake in the pharmaceutical customs synthesis business<br />

of Rhodia Pharma Solutions including the technology<br />

Strides Acrolab Biopharma Venezuela Jun-05 Est. < 5.0 60% in Venezuelan pharmaceutical and marketing company<br />

Strides Acrolab Sterile manufacturing<br />

facility<br />

Poland Jul-05 8.0 100% in Poland based sterile manufacturing facility<br />

specializing in small volume parenterals<br />

Strides Acrolab Beltapharm S.p.A Italy Jul-05 1.9 70% stake in Milan headquartered, semi solids and liquids<br />

producer<br />

Sun Pharmaceutical Caraco USA Mar-04 Est. < 50.0 63.1% stake in Detroit-based company<br />

Sun Pharmaceutical ICN CO Hungary Ltd Hungary Aug-05 Est. < 10.0 Purchase of manufacturing facilities in Hungary and Ohio<br />

from Valeant<br />

Sun Pharmaceutical Women’s First<br />

Healthcare<br />

USA Sep-04 5.4 Purchase of three niche brands with sales of US$ 7.6mn<br />

Sun Pharmaceutical Able Laboratories <strong>Inc</strong>. USA Dec-05 23.2 100% of the dosage form business of Able<br />

Suven Life Sciences Synthon Chiragenics<br />

Corp<br />

USA May-03 Est. < 20.0 100.05 of the assets of New Jersey-based leader in<br />

carbohydrate-based chiral technology for pharmaceuticals;<br />

E&Y estimates the opportunity at US$20.0mn<br />

Themis Medicare Gedeon Richter RT Hungary Aug-04 Est. < 5.0 No details available<br />

Torrent<br />

Pharmaceuticals<br />

Heumann Pharma<br />

GmbH<br />

Germany Jun-05 Est. < 5.0 100% stake in a generic drug company with the Pfizer group<br />

Wockhardt CP Pharmaceuticals UK Jul-03 19.3 100% stake in the UK based generic company with sales of<br />

US$56.1mn<br />

Wockhardt Esparma GmbH Germany May-04 10.9 100% stake in a German generic business<br />

25


The Deal Details<br />

Metals & Mining Sector<br />

Acquirer Target Country Date Deal Size Remarks<br />

Essar Steel 2 Steel Mills UK Sep-05 100.4 100% stake in Hy-Grade Pellets (HGPL) and Steel Corporation<br />

of Gujarat (SCGL) from Stemcor, UK<br />

Gujarat NRE Coke Bellambi & Balgownie<br />

coal mine<br />

Australia Oct-04 17.5 100% stake in Australia based NRE No. 1 colliery which holds<br />

the Bulli, Balgownie and Wongawilli seams; estimated<br />

reserves of 300.0mnt of coking coal<br />

Gujarat NRE Coke Zelos Resources NL Australia Jun-05 13.6 18.6% stake in the Australian mining company having<br />

exploration license in iron ore and other base metals like<br />

gold, copper, platinum, nickel and zinc<br />

Gujarat NRE Coke Rey Resources Ltd. Australia Oct-05 1.5 19.9% stake in Sydney based resources company<br />

Hindalco Mount Gordon copper<br />

mine<br />

Australia Jan-03 14.3 100% stake in the Australian copper mines from Western<br />

metals Ltd<br />

Hindalco Nifty Copper ops Australia Oct-05 94.0 50% stake interest in Maroochydore exploration project from<br />

Straits Resources Limited, the listed Australian mining<br />

company<br />

Jindal SAW Imphy Ugine Precision France Aug-04 Est. < 20.0 70% stake in a JV pact with Imphy Ugine Precision, one of the<br />

divisions of Arcelor <strong>Group</strong> for manufacturing of High<br />

Jindal Stainless Stainless steel Cold<br />

Rolling Plant<br />

Precision Metal Equipments<br />

Indonesia Jul-04 25.0 100% stake interest in a running 50ktpa capacity stainless<br />

steel CR plant in Indonesia from PT. Maspion Stainless Steel<br />

Indonesia on asset acquisition basis<br />

Tata Steel Natsteel Asia pte ltd SE Asia Sep-03 283.7 100% stake in the Singapore based company which owns steel<br />

mills in China, Thailand, Vietnam, Philippines and Australia,<br />

with a capacity of 2.0mntpa; 26% per cent equity in Southern<br />

Tata Steel Carborough downs coal<br />

project<br />

Steel Berhad, a 1.3mntpa steel maker in Malaysia<br />

Australia Jul-05 Est. < 5.0 5% stake interest in the Carborough Downs coal project<br />

located in Queensland<br />

Tata Steel Millennium Steel pcl Thailand Dec-05 175.0 100% stake in Thailand based company having a capacity of<br />

1.7mntpa producing long products for construction and<br />

engineering steel for auto industries<br />

26


The Deal Details<br />

Oil & Gas Sector<br />

Acquirer Acquirer Target Target Country Country Date Date Deal Deal Size Size Remarks Remarks<br />

Gail <strong>India</strong> Fayum Gas Co. Egypt Jan-04 9.7 19% stake in the Egypt based city gas distribution company<br />

Gail <strong>India</strong> Shell CNG, Egypt Egypt Jan-04 1.7 22% stake in the Egypt based CNG company<br />

Gail <strong>India</strong> NATGas Egypt Aug-04 19.0 15% stake in Egypt based natural Gas company<br />

Gail <strong>India</strong> China Gas Holdings<br />

Ltd.<br />

China Feb-05 31.0 10% stake in the Chinese company<br />

ONGC Sakhalin-1 PSA Project Russia Dec-00 323.0 100% stake in the Sakhalin project from OAO Rpsneft Oil<br />

Company<br />

ONGC Myanmar natural Gas<br />

Venture<br />

ONGC Greater Nile Oil<br />

Project<br />

ONGC 2 Sudanese Oil<br />

Interests<br />

Myanmar Jan-02 Est. < 50.0 20% participating interest from Daewoo International<br />

Sudan Oct-02 766.1 25% stake in the project from Talisman Energy Co<br />

Sudan Aug-03 136.5 100% stake interest in assets from OMV AG<br />

ONGC Offshore Oil Field Australia Aug-04 Est. < 50.0 100% stake in the Australian offshore oilfield from Antrim<br />

Energy <strong>Inc</strong>.<br />

ONGC Oil Field / Ivory Coast West Africa Sep-04 Est. < 50.0 30% participating interest from VANCO Energy <strong>Inc</strong><br />

ONGC 36 Oil fields in Syria Syria Jul-05 Est. < 50.0 100% stake interest in the assets from Petro Canada<br />

ONGC Cuban oil exploration<br />

blocks 25 to 29, 35 and<br />

36<br />

ONGC Vietnam Oil<br />

Exploration Block 128<br />

& Block 127<br />

Cuba Sep-05 Est. < 50.0 30% participating interest<br />

Vietnam Nov-05 Est. < 50.0 No details available<br />

27


The Deal Details<br />

Software / BPO Sector<br />

Acquirer Target Country Date Deal Size Remarks<br />

3i Infotech Ivory Consulting USA Jun-00 Est. < 5.0 100% stake in US-based software service provider; annual<br />

revenue of US$10mn<br />

3i Infotech Command Systems <strong>Inc</strong> USA Jan-01 20.0 100% stake in US based information technology solutions and<br />

services company<br />

3i Infotech Insyst Technology <strong>Inc</strong> Middle East Oct-01 Est. < 5.0 100% stake in Middle east based ERP product company<br />

3i Infotech Pipal Research USA Sep-04 3.9 51% stake in Illinois based equity research BPO<br />

3i Infotech Formulaware <strong>Inc</strong> USA Nov-05 Est. < 5.0 100% stake in US based software company specializing in<br />

software aimed at the chemical and paint industries<br />

Aftek Infosys Arexera Information<br />

Tech<br />

Germany Mar-<br />

03/Dec-<br />

05<br />

Est. < 20.0 100% stake in German knowledge management software<br />

company with focus on Processes, Information and<br />

Infrastructure management<br />

Axis IT&T Axis <strong>Inc</strong> USA Aug-03 2.3 IT&T acquired 70% stake in the merged entity between IT&T<br />

and Axis<br />

Datamatics<br />

Technologies<br />

Datamatics<br />

Technologies<br />

Saztec International<br />

<strong>Inc</strong><br />

USA Oct-00 1.4 100% stake in a US based diversified information processing<br />

company<br />

Corpay Solutions <strong>Inc</strong> USA Oct-03 4.5 100% stake in Detroit based company specializing in finance<br />

and accounting BPO services<br />

Four Soft Cargomate Netherlands<br />

Four Soft Comex Frontier Singapore,<br />

Malaysia<br />

Oct-04 1.9 100% stake in Netherlands based premier transportation and<br />

freight forwarding software solutions company<br />

May-05 1.3 100% stake in Singapore based Software solutions provider<br />

and a Malaysian ecommerce solutions provider for Logistics<br />

Genpact Creditek Corp USA Jul-05 Est. < 5.0 100% stake in US based provider of order-to-cash cycle<br />

outsourcing and enterprise receivables management services;<br />

annual revenues of US$20.4mn in 2004<br />

28


The Deal Details<br />

Software / BPO Sector contd.<br />

Acquirer Target Country Date Deal Size Remarks<br />

I-Flex Solutions Equinox Corp. USA Nov-04 Est. < 5.0 100% stake in US based mortgage platform based company<br />

I-Flex Solutions Login SA France Nov-04 Est. < 5.0 100% stake in France based specialist treasury front-end<br />

solution provider<br />

IKF Technologies NPR Solutions <strong>Inc</strong> USA Feb-05 0.3 100% stake in US based provider of I.T services<br />

Infosys Tech Expert Information<br />

Services<br />

Australia Dec-03 22.9 100% stake in Australian based IT firm; Annual sales of<br />

US$31.5mn<br />

Kaashyap Radiant Softpride Systems <strong>Inc</strong> USA Jun-01 Est. < 5.0 No details available<br />

KLG Systel COADE <strong>Inc</strong>. USA Jan-00 11.5 100% stake in US based engineering software developer<br />

KPIT Cummins<br />

Infosystems<br />

KPIT Cummins<br />

Infosystems<br />

KPIT Cummins<br />

Infosystems<br />

Panex Consulting USA Aug-03 1.7 100% stake in Houston-based IT Consulting company<br />

Pivolis France Nov-05 2.1 Substantial stake in French based company providing<br />

offshore consulting services<br />

Solvecentral.com <strong>Inc</strong> USA Nov-05 2.0 100% stake in US based software company<br />

Mahindra & Mahindra Bristlecone <strong>Inc</strong> USA Feb-04 7.0 100% stake in San Jose, California based business process and<br />

technology consulting firm<br />

Mastek Limited Entegram LLC USA Oct-05 0.8 100% stake in US based software solutions company<br />

specializing in customs application development; Annual<br />

revenue of US$1.5mn<br />

Megasoft Vector Consulting <strong>Inc</strong> USA Jul-01 Est. < 5.0 100% stake in Atlanta, US-based software services company;<br />

Annual revenue of US$10.0mn<br />

Melstar Information<br />

Tech<br />

Melstar Information<br />

Tech<br />

Linkhand PLC UK Sep-00 7.0 100% stake in UK-based IT firm along with its two subsidiaries<br />

ITC Consulting GmbH Switzerland Sep-00 1.5 100% stake in UK operations of Zurich based ITC Consulting<br />

29


The Deal Details<br />

Software / BPO Sector contd.<br />

Acquirer Target Country Date Deal Size Remarks<br />

I-Flex Solutions Equinox Corp. USA Nov-04 Est. < 5.0 100% stake in US based mortgage platform based company<br />

I-Flex Solutions Login SA France Nov-04 Est. < 5.0 100% stake in France based specialist treasury front-end<br />

solution provider<br />

IKF Technologies NPR Solutions <strong>Inc</strong> USA Feb-05 0.3 100% stake in US based provider of I.T services<br />

Infosys Tech Expert Information<br />

Services<br />

Australia Dec-03 22.9 100% stake in Australian based IT firm; Annual sales of<br />

US$31.5mn<br />

Kaashyap Radiant Softpride Systems <strong>Inc</strong> USA Jun-01 Est. < 5.0 No details available<br />

KLG Systel COADE <strong>Inc</strong>. USA Jan-00 11.5 100% stake in US based engineering software developer<br />

KPIT Cummins<br />

Infosystems<br />

KPIT Cummins<br />

Infosystems<br />

KPIT Cummins<br />

Infosystems<br />

Panex Consulting USA Aug-03 1.7 100% stake in Houston-based IT Consulting company<br />

Pivolis France Nov-05 2.1 Substantial stake in French based company providing<br />

offshore consulting services<br />

Solvecentral.com <strong>Inc</strong> USA Nov-05 2.0 100% stake in US based software company<br />

Mahindra & Mahindra Bristlecone <strong>Inc</strong> USA Feb-04 7.0 100% stake in San Jose, California based business process and<br />

technology consulting firm<br />

Mastek Limited Entegram LLC USA Oct-05 0.8 100% stake in US based software solutions company<br />

specializing in customs application development; Annual<br />

revenue of US$1.5mn<br />

Megasoft Vector Consulting <strong>Inc</strong> USA Jul-01 Est. < 5.0 100% stake in Atlanta, US-based software services company;<br />

Annual revenue of US$10.0mn<br />

Melstar Information<br />

Tech<br />

Melstar Information<br />

Tech<br />

Linkhand PLC UK Sep-00 7.0 100% stake in UK-based IT firm along with its two subsidiaries<br />

ITC Consulting GmbH Switzerland<br />

Sep-00 1.5 100% stake in UK operations of Zurich based ITC Consulting<br />

30


The Deal Details<br />

Software / BPO Sector contd.<br />

Acquirer Target Country Date Deal Size Remarks<br />

Moschip<br />

Semiconductor<br />

Verasity Technologies<br />

<strong>Inc</strong><br />

USA Dec-03 8.7 100% stake in a privately held corporation, providing silicon,<br />

software and support for last mile Internet connected<br />

security solutions<br />

Moser Baer CAPCO UK Jun-00 5.2 No details available<br />

Mphasis BFL Navion Software<br />

Development<br />

China Oct-02 Est. < 5.0 100% stake in the captive software maker for financial giant<br />

Capital One<br />

Mphasis BFL Princeton Consulting UK Feb-05 8.4 100% stake in UK based company having annual sales of<br />

US$13.4mn<br />

Mphasis BFL Eldorado Computing<br />

<strong>Inc</strong>.<br />

USA Mar-05 16.5 100% stake in US based company having annual sales of<br />

US$10.0mn<br />

NIIT Osprey Systems <strong>Inc</strong> USA Mar-02 3.0 100% stake in US based privately held company engaged in<br />

providing SAP solutions and services; Annual revenues were<br />

Orient Information<br />

Technology<br />

Professional Access<br />

Ltd.<br />

over US$10mn in 2001<br />

USA Mar-02 36.9 62% stake in US based software services company; annual<br />

revenues of US$40.0mn<br />

Patni Computer Cymbal Corp USA Oct-04 68.0 100% stake in California based IT firm; Annual turnover of<br />

US$32mn<br />

Polaris Software SIDOUN GmbH Germany Feb-01 1.1 20% stake in German based software company<br />

Sai Info Call Centre College UK UK May-01 Est. < 5.0 100% stake in UK-based call centre training and education<br />

centre<br />

Sarla Technologies Synapse Systems LLC USA Jan-04 Est. < 5.0 100% stake in Pittsburgh, Pennsylvania-based software<br />

development and automation firm<br />

Satyam Computer Medbiquitous Services<br />

<strong>Inc</strong><br />

USA Oct-01 1.0 7% stake in US based IT company<br />

Satyam Computer Citisoft UK Apr-05 23.2 100% stake in European business and systems consulting firm<br />

31


The Deal Details<br />

Software / BPO Sector contd.<br />

Acquirer Target Country Date Deal Size Remarks<br />

Satyam Computer Knowledge Dynamics<br />

Pte Ltd.<br />

Singapore Jul-05 3.3 100% stake in Singapore-based intelligence solutions<br />

consultancy firm<br />

Scandent BWH France France Jul-05 Est. < 5.0 100% stake in France based technology firm focused on<br />

enterprise resources planning<br />

Scandent Cambridge Services<br />

Holding<br />

USA Sep-05 120.0 75% stake in US based BPO business; Annual sales of<br />

US$300mn and EBITDA of US$30mn<br />

Secova Eservices Empact EBS <strong>Inc</strong> USA Dec-04 Est. < 5.0 No details available<br />

Servion Global<br />

Solutions<br />

5by5 Networks,<br />

<strong>Inc</strong>orporated<br />

USA Jan-06 Est. < 5.0 100% stake in US based technological company<br />

Silverline Tech Starpoint Solutions USA Aug-00 15.0 No details available; reported deal value of US$15mn<br />

Silverline Tech SeraNova USA Oct-00 89.8 100% stake in US based designs and implements Internetbased<br />

software in a stock transaction<br />

SK Technologies Cirilium Holdings <strong>Inc</strong>. USA Jun-04 89.6 No details available; Deal value as reported by company<br />

SSI Limited Albionnorion LLC USA Sep-00 58.9 100% stake in US based IT solutions provider in a stock<br />

transaction<br />

Subex Systems Fraud Management<br />

<strong>Group</strong><br />

Subex Systems Fraud Centurion<br />

Product Suite<br />

TCS Financial Network<br />

Services<br />

France Jul-04 3.0 No details available<br />

USA Aug-04 Est. < 5.0 No details available<br />

Australia Oct-05 26.1 100% stake in Australian based provider of sophisticated,<br />

mission-critical systems for the banking and finance industry<br />

around the world<br />

TCS ComiCrom Chile Nov-05 23.0 100% of Chile based IT firm; 1257 employees; Annual<br />

revenues of US$35.5mn<br />

Teledata Informatics Teledata Marine<br />

Systems Pte Ltd<br />

Singapore Jul-04 Est. < 5.0 21.1% stake in Singapore based firm funded by the Economic<br />

Development Board of Singapore<br />

32


The Deal Details<br />

Software / BPO Sector contd.<br />

Acquirer Target Country Date Deal Size Remarks<br />

Teledata Informatics Bitech Dubai Dubai Sep-04 Est. < 5.0 100% of Bitech Dubai<br />

Teledata Informatics Bitech Singapore Singapore Sep-04 Est. < 5.0 51% stake in Bitech Singapore<br />

Teledata Informatics Insoft Systems Pte Ltd Singapore Sep-04 Est. < 5.0 No details available<br />

Teledata Informatics Vanguard Technologies<br />

LLC<br />

USA Nov-05 Est. < 5.0 100% stake in US based company which specializes in<br />

providing services based on SAP<br />

Teledata Informatics Picnic Marine Company Thailand Dec-05 43.2 70% stake in Thailand based company; 200 employees;<br />

Annual turnover of US$9.0mn; deal value as reported by<br />

Teledata Informatics Alphasoft Services<br />

Corporation (ASC)<br />

company<br />

USA Mar-06 14.2 100% stake in US based company providing high quality IT<br />

services;<br />

Virinchi Technologies Ksoft Systems <strong>Inc</strong> USA Aug-05 2.7 100% stake in New Jersey, USA based company focusing on<br />

SAP implementations; 40 employees<br />

Wipro Utility Consultancy<br />

Business of AMS<br />

USA Nov-02 26.0 100% stake in US based IT firm<br />

Wipro Nervewire inc. USA Apr-03 18.7 100% stake in US based IT Consulting firm<br />

Wipro Newlogic Technologies Austria Dec-05 56.4 100% stake in Austria based Bluetooth and Wireless LAN<br />

design firm<br />

Wipro mPower <strong>Inc</strong>. USA Dec-05 28.0 100% stake in US based IT firm; Annual revenues of<br />

US$18.0mn<br />

Wipro cMango inc. USA Feb-06 20.0 100% stake in US based IT firm; Annual revenues of<br />

US$13.0mn<br />

WNS Global Servies Trinity Partners USA Nov-05 63.0 100% stake in Arizona-based mortgage BPO<br />

Zensar Technologi es Broadgate Systems <strong>Inc</strong> USA Aug-04 Est. < 5.0 No details available<br />

Zensar Technologies OBT Global <strong>Inc</strong> USA Dec-05 Est. < 5.0 100% stake in US based SAP services provider<br />

33


The Deal Details<br />

Others<br />

Acquirer Target Country Date Deal Size Remarks<br />

Allcargo Movers (I) Ecu-Line N.V. Europe Jun-05 9.0 33.8% stake in Europe's largest Non Vessel Operated Common<br />

Carrier; Target sales of EUR180mn (US$220mn) in 2004<br />

Apollo Tyres Dunlop Tyres South<br />

Africa<br />

Jan-06 62.0 100% stake in the South Africa based company producing bias<br />

and radial products; annual turnover of US$210mn in CY2005<br />

Bilcare ProClinical <strong>Inc</strong>. USA Jul-05 Est. < 5.0 100% stake in Phoenixville based pharmaceutical services and<br />

packaging company<br />

Carborundum<br />

Universal<br />

Continental Engines Vege <strong>Group</strong> (European<br />

business)<br />

Abrasive Enterprises Canada Feb-06 1.7 100% stake in a closely held company based at Summerside,<br />

Canada<br />

Netherlands<br />

Oct-05 6.0 100% stake in Netherlands based engine and related parts<br />

manufacturer<br />

Country Club <strong>India</strong> Babylon Hotels Sri Lanka Feb-06 2.2 100% stake in Sri Lanka based Babylon property; 30-suites<br />

Crompton Greaves Pauwels Transformer<br />

business<br />

Belgium Feb-05 42.5 100% stake in Belgium based manufacturer of three-phase<br />

transformers<br />

Cyber Media SX2 Media Labs USA Feb-06 Est. < 5.0 20% stake in New York-based Sx2 Media Labs LLC, a company<br />

formed by David Sills and Stoneybrook Capital<br />

Essel Propack Propack Holdings AG Switzerland<br />

Nov-00 11.0 Essel became the world's largest laminated tube co. after<br />

this acquisition<br />

Essel Propack Arista Tub es UK Aug-04 Est. < 5.0 100% stake in UK based seamless plastic tubes manufacturer<br />

Essel Propack Telcon Packaging UK Apr-05 Est. < 5.0 100% stake in UK based laminated tube manufacturer having<br />

12% market share<br />

Essel Propack Tacpro <strong>Inc</strong>. USA,<br />

Avalon Medical<br />

services, Singapore<br />

USA,<br />

Singapore<br />

Mar-06 10.7 85% stake in California based Tacpro and Singapore based<br />

Avalon; Tacpro has annual sales of US$9.0mn<br />

GMR Odeon Ltd. Mauritius Mar-03 Est. < 5.0 No details available<br />

34


The Deal Details<br />

Others contd.<br />

Acquirer Target Country Date Deal Size Remarks<br />

Graphite <strong>India</strong> Conradty <strong>Group</strong> Germany Jul-04 13.6 100% stake in the German graphite electrodes manufacturer<br />

Gujarat Glass Glass <strong>Group</strong> <strong>Inc</strong>. USA Jul-05 Est. < 10.0 100% purchase of Flat river glass plant and 2 operations in<br />

New Jersey<br />

Havell's <strong>India</strong> Standard Electronics<br />

<strong>Inc</strong><br />

ICICI Bank Investitsionno-<br />

Kreditny Bank<br />

IFGL Refractories Monocon International<br />

Refrac<br />

USA Apr-00 4.1 100% purchase of electrical equipment company<br />

Russia May-05 Est. < 5.0 100% stake in the 3 branch Russian Bank having assets worth<br />

US$4.4mn of which US$2.5mn are loan assets<br />

UK Aug-05 16.1 No details available<br />

<strong>India</strong>n Hotels Pierre Hotel USA June –05 50.0 Purchase of luxury hotel of Manhattan Fifth Avenue<br />

<strong>India</strong>n Hotels W Hotel/SYDNEY Australia Dec-05 36.0 Purchase of Boutique hotel in Australia<br />

Infomedia <strong>India</strong> Keyword <strong>Group</strong> Ltd UK Dec-05 3.2 Purchase of pre-press company along with its 49% holding in<br />

Cepha Imaging, <strong>India</strong><br />

ISG Novasoft Gmaccm Technology Europe Oct-05 Est. < 5.0 100% stake in the financial services resource firm<br />

Jindal PolyFilms REXOR SA France Nov-03 10.1 100% stake in flexible & luxury packaging film maker; annual<br />

turnover of US$34.0mn<br />

Kirloskar Brothers SSP Branded water &<br />

fire pumps<br />

Motherson Sumi<br />

Systems<br />

G+S Kunststofftechnik<br />

GmbH<br />

PSL Flecon Multi System<br />

PTE LTD<br />

UK Nov-03 8.4 100% of assets and business of pump manufacturing company<br />

in UK<br />

Germany Jun-05 2.5 100% stake in Germany based plastics injection molding<br />

company; annual turnover of EUR9.0mn<br />

Singapore May-00 0.1 No details available<br />

35


The Deal Details<br />

Others contd.<br />

Acquirer Target Country Date Deal Size Remarks<br />

Reliance Gateway<br />

Net<br />

Flag Telecom USA Oct-03 191.2 100% stake in the US company which has laid submarine<br />

cables of around 50,000 km across the globe and has hubs in<br />

Middle East and the United States<br />

Reliance Industries Trevira GmbH Germany Jun-04 97.4 100% stake in German based manufacturers of polyester<br />

fibres and filament yarns; Annual turnover of EUR316mn in<br />

SBI Giro Commercial Bank<br />

Ltd.<br />

SBI Ocean International<br />

Bank<br />

Kenya Oct-05 Est. < 10.0<br />

2003<br />

76% stake in Kenya based bank<br />

Mauritius Oct-05 10.0 No details available<br />

SBI Bank Indomonex PT Indonesia Nov-05 Est. < 10.0 76% stake in Indonesia-based bank with seven branches in<br />

Jakarta, Bandung and Surabaya<br />

Sheela Foam Joyce Corporation<br />

Limited<br />

Australia Aug-05 12.1 100% stake in Australian listed company dealing in foam<br />

products<br />

Shriram <strong>Group</strong> & EU Dewind AG Germany Jul-05 0.1 100% stake in the turbine business of FKI<br />

Tata Sons News Corp-CL A N/A Jan-04 Est. < 5.0 No details available<br />

Tembec <strong>Inc</strong>; Aditya<br />

Birla <strong>Group</strong><br />

St. Anne-Nackawic<br />

Pulp Company Ltd<br />

United Phosphorus Advanta Netherlands Netherlands<br />

Canada Nov-05 100.0 100% acquisition was made through a JV between Aditya<br />

Birla <strong>Group</strong> and Tembec in which Aditya Birla <strong>Group</strong> will be<br />

the majority equity holder<br />

Feb-06 115.0 100% stake in the seed business of Advanta <strong>Group</strong>; annual<br />

turnover of US$74.5mn<br />

Usha Martin Limted Brunton Shaw UK Sep-00 4.6 100% stake in UK based ropes manufacturer and supplier<br />

Videocon<br />

International<br />

Videocon<br />

International<br />

Thomson SA (Italian<br />

tube activity)<br />

Thomson SA (Cathode<br />

Ray Tube business)<br />

Italy Jan-05 169.9 No details available<br />

Europe,<br />

China<br />

Jun-05 289.2 100% of the Picture tube manufacturing operations of<br />

Thomson SA including three manufacturing facilities in<br />

Poland, Mexico and China.<br />

VSNL Tyco Global Network USA Nov-04 130.0 No details available<br />

VSNL Teleglobe International<br />

Holdings<br />

USA Jul-05 254.3 100% stake in US based telecoms network services company<br />

36


<strong>MAPE</strong> <strong>Advisory</strong> <strong>Group</strong> is a boutique investment banking firm focusing on Mergers &<br />

Acquisitions (M&A) and Private Equity (PE) deals. A Bloomberg ranked firm, <strong>MAPE</strong> has<br />

closed 35 deals totaling US$ 350mn in the last four years. The firm has 20 investment<br />

banking professionals working out of offices in Bangalore, Chennai, Delhi and Mumbai.<br />

Select Transactions


210 Prestige Center Point<br />

Cunningham Road<br />

Bangalore - 560052<br />

Tel: 080 2235 1650/1/2<br />

<strong>MAPE</strong> <strong>Advisory</strong> <strong>Group</strong> Pvt Ltd<br />

7C, P M Towers<br />

37 Greams Road<br />

Chennai 600 006<br />

Tel: 044 2829 5377/8<br />

www.mapegroup.com<br />

6, 1st Floor<br />

Augusta Point<br />

DLF Golf Course Road<br />

Gurgaon<br />

Tel: +91-98993 77446<br />

IL&FS Financial Center<br />

2nd Floor, Quadrant 'B'<br />

Bandra Kurla Complex,<br />

Mumbai 400 051<br />

Tel: 022 2653 3644/5<br />

Disclaimer: The information and views presented in this report are prepared by <strong>MAPE</strong> <strong>Advisory</strong> Pvt. Ltd. The information contained herein is based on our analysis and up on sources that we<br />

consider reliable. We, however, do not vouch for the accuracy or the completeness thereof. This material is for personal information and we are not responsible for any loss incurred based upon it.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!